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ABSTRACT 
 Nucleic acid (NA) purification from clinical samples is commonly achieved using 
silica solid phase extraction in the presence of a chaotropic salt. Versions of these 
protocols have been adapted for point of care (POC) diagnostic devices in miniaturized 
platforms. Most such protocols require a high net amount of input NA, which is often 
achieved by adding exogenous carrier NA to the clinical sample. As a result, for samples 
containing less than 1 µg of total NA, NA recovery is low in the absence of carrier NA. 
Clinical samples used in POC diagnostics may contain very low NA concentrations  
(~1 ng/ml), which result in NA-limited interactions with the solid phase that are outside 
the dynamic range of POC diagnostics. This work is a study of DNA-silica interactions in 
the DNA-limiting regime to gain fundamental understanding of the mechanisms at play 
in order to increase the dynamic range and sensitivity of miniaturized NA based POC 
diagnostics. DNA adsorption and recovery from silica surfaces for concentrations less 
than 1 µg/ml are studied. A protocol was designed and developed to systematically 
quantify the adsorption of DNA onto a silica surface and the amount of DNA recovered 
		 vii 
by elution at very low concentrations. Various adsorption conditions were examined 
including a range of pH, different chaotropes, and DNA concentrations down to  
2.5 pg/ml. DNA recovery was further optimized for low concentration samples by 
varying elution buffers. DNA-silica adsorption was enhanced by low pH and was further 
improved by the presence of a chaotrope. Different adsorption conditions had little effect 
on DNA recovery using low salt, high pH elution buffers, but DNA recovery did exceed 
40% when adsorbed initially with 5 M guanidinium thiocyanate at pH 5.2. Recovery was 
enhanced by eluting with 95 °C formamide or 1 M NaOH, supporting the hypothesis that 
DNA-silica interactions are dominated by hydrophobic forces and hydrogen bonding. 
While heated formamide and NaOH are non-ideal elution buffers for practical POC 
devices, these results are important for engineering a set of optimized reagents and 
conditions that could maximize DNA recovery from a microfluidic POC silica system. 
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CHAPTER 1 
INTRODUCTION 	
Nucleic acid (NA) identification and quantification in crude biological samples is 
fundamental to the development of molecular diagnostics. In almost every case, this 
process first requires purification of NA from the complicated mixture of biomolecules 
found in the cells and tissues of interest.1 Samples investigated in this manner include 
specimens from forensic investigations, samples generated in the course of biological 
research, and clinical samples for diagnostic procedures.2–4 The global diagnostic market 
alone was $34.6 billion, and growing at an 8% rate in 2012.5 Making the process of NA 
extraction and purification more effective and less complicated will enable the translation 
of more NA based point of care (POC) diagnostic tests into the marketplace.6  
Currently, NA is purified either by a wet chemical method, usually 
phenol/chloroform extraction, or a solid phase extraction (SPE) method, commonly 
utilizing silica as the solid phase. The SPE method is often preferred, since 
phenol/chloroform requires separation of two liquid phases by hand resulting in 
volumetric losses and also generates toxic waste.7 In contrast, the SPE method extracts 
NA from crude samples onto the silica surface with an adsorption buffer and recovers it 
by eluting with an elution buffer.8 The simplicity of the SPE method makes it ideal for 
POC and low resource setting applications.9 
Commercial kits for NA purification using silica exist, but they have limitations.10 
These kits are based on the fact that NA adsorption to silica is greatly enhanced by the 
presence of a chaotrope, an ion that disrupts hydrogen bonding.11,12 This adsorption is 
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known to be influenced by pH, ionic strength, and the nature of the chaotrope present, but 
many fundamental questions about the mechanism remain unanswered.13 This includes 
what drives NA onto the silica surface, what molecular interactions keep the NA 
adsorbed on the surface, and can elution buffers be engineered to improve recover? 
Commercial NA purification kits (e.g., Qiagen, Valencia, CA) use guanidinium 
hydrochloride (GuHCl) as the chaotrope.10 However, these kits are limited to samples 
with at least 1 µg of total DNA.10 This limitation makes it difficult, if not impossible, to 
use for samples with very low amounts and concentrations of DNA, specifically for 
cancer detection, early stage infectious bacteria, and virus detection.14–16 Further, single 
cell and small cell population studies have been enabled by the wide use of microfluidic 
technologies in recent years and the ability to isolate NA from small populations reliably 
and quantitatively is important for systems and synthetic biology in addition to basic 
disease research.17,18 
This thesis will address the need to extract and purify DNA from very low 
concentration samples. It will first look at sepsis as a case study. In sepsis, bacteria, virus, 
or fungi enter the bloodstream, and toxicity and death can occur at very low 
concentrations of the foreign microorganism.19 Blood tests for sepsis represent the 
quintessential high volume, low concentration challenge for POC diagnostics today, and 
this study will evaluate non-POC gold standard methods to purify NA. The thesis will 
then take an experimental approach toward characterizing DNA-silica interactions in the 
DNA-limiting regime and elucidating the mechanisms of NA-silica surface interactions. 
Many of these mechanisms have been postulated but have not been demonstrated 
	3 
experimentally with careful, quantitative studies. Quantification is carried out using the 
quantitative polymerase chain reaction (qPCR). A system was designed and extensively 
characterized to mimic the conditions in a microscale POC NA test.  
Finally, a version of the system was tested for the challenging diagnostic 
application of sepsis.  
The structure of the thesis is structured as follows: 
Chapter 2 – The scientific underpinnings of the study. 
Chapter 3 – The case study on sepsis and diagnosing it via DNA purification. 
Chapter 4 – Designing a system to assess DNA purification via silica solid surface. 
Chapter 5 – Assessing DNA adsorption and recovery via silica solid phase. 
Chapter 6 – Discussion on chaotropic mediated DNA-silica mechanism. 
Chapter 7 – Summary of conclusions and potential future work. 
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CHAPTER 2 
GENERAL PRINCIPLES 
  
2.1 SOLID PHASE EXTRACTIONS IN MEDICAL DIAGNOSTICS 
 
Medical diagnostic devices often require the purification of a molecular target 
from a crude biological sample.4,20 The general workflow for a device that detects nucleic 
acids (NAs) is shown in Figure 1: 1) a patient sample is collected, 2) the cells in the 
sample are lysed to release target NAs, 3) the target NAs are purified from the crude 
lysate, 4) the target NA is amplified, and 5) the device quantifies the amount of target in 
the original patient sample through the emission of light or electrochemical detection. 
 
Figure 1. Schematic of NA diagnostic devices. The general workflow begins with a 
patient sample that may contain human cells, bacteria, viruses, fungi, or free-floating NA. 
The sample is lysed to expose all NA in solution and the NA is subsequently separated 
from the other biomolecules present in the solution. The target NA is then amplified to 
increase the signal and is finally detected for medical professionals to determine a 
diagnosis. Amplification isn’t necessary for samples with large amount of target NA. 
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Some applications do not require step (4) if the initial amount of target NA is large. Other 
applications only require semi-quantitative readouts, since clinical decision-making can 
be altered by a simple yes or no answer. Research is currently being conducted to 
improve all aspects of such devices and to optimize conditions for specific applications. 
This thesis focuses on improving the purification of NAs from very low concentration 
crude input samples. Specifically, the work will be limited to procedures optimized for 
total DNA extraction. Methods to extend the results to RNA will be covered in the 
discussion in Section 2.2.2.  
The gold standard NA purification methods are phenol/chloroform extraction and 
solid phase extraction (SPE).1,7 Both methods yield pure NAs in buffer. Dilute solutions 
can then be ethanol precipitated to concentrate the NA before downstream amplification 
and detection. For phenol/chloroform extraction, first, lysis buffer is added to the sample, 
which lyses cells, most bacteria (depending on the robustness of the cell wall), virions, 
etc., to release all NAs. Then the volume is doubled with equal parts 
phenol:chloroform,21 vortexed, and spun down via centrifuge, resulting in a biphasic 
liquid with an aqueous layer containing the NA on top and an organic bottom layer 
containing the majority of the proteins. Specifically for DNA, since its isoelectric point is 
pH 5,22 the pH of the sample with the lysis buffer should be neutral or basic, or the DNA 
will be lost in the organic phase. After centrifugation, the top layer is collected by hand 
and the DNA is purified via ethanol precipitation, the specifics of which will be discussed 
in Section 2.3.2.  
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The second commonly used method is SPE. Silica is commonly used for NA 
purification and is commercially available through Qiagen (Valencia, CA, USA). In order 
to achieve high surface area, silica SPE columns are made up of silica particles or fibers. 
The general protocol is shown in Figure 2. First, a lysis buffer and/or a loading buffer is 
added to the sample. The mixture is then flowed through a silica SPE to capture the NA; 
the remaining non NA components of the crude mixture flow through without binding to 
the column.23 The loading buffer is vital to create proper adsorption conditions.11 This 
buffer is commonly buffered to a neutral pH and contains large amounts of chaotropic 
salt.10 Thus, the loading buffer has some lytic capabilities and can be combined with lysis 
buffer components to simplify the protocol. After NA has been loaded onto the silica, it is 
 
Figure 2. Generic workflow of NA silica-SPE column. A biological sample is lysed to 
release all NA into solution. The solution is combined with an adsorption buffer if the 
lysis buffer doesn’t promote NA adsorption onto the silica surface. The resulting solution 
is subsequently flowed through the porous silica column, where the NA adsorbs onto the 
surface while other biomolecules flow through the column. The silica is then washed to 
remove any remaining adsorption buffer, salts, or lingering non-NA biomolecules. The 
NA is finally eluted with a low salt, high pH buffer. The resulting sample is pure enough 
to use in molecular tests. 
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washed with 70% ethanol to remove excess salt from the solid phase. The NA is finally 
eluted with a low salt, high pH buffer. The buffer is chosen so that it will not interfere 
with downstream quantification methods.24 Again, the resulting purified NA can be 
ethanol precipitated to improve purity and increase the effective concentration.25 The 
omission of the manual liquid phase separation using the SPE makes it less complex and 
allows for easy integration in diagnostic devices. 
Silica SPEs have been integrated into an array of diagnostic devices. Qiagen 
commercial kids are optimized for DNA and RNA purification from a variety of 
biological sources. These protocols are extraction and purification protocols only, and the 
purified NAs have to be pipetted into other reaction vessels for amplification and 
detection. Similar protocols have been miniaturized for use with C. difficile, E. coli, 
mammalian cells, and influenza.26–28 
Silica has been incorporated into integrated devices that can provide rapid 
readouts as compared to standard methods. Boom et al. began by mixing DNA and silica 
in a tube reaction and separated the silica from solution via centrifugation.23 This was 
followed by silica-coated magnetic particles to enable magnetic separation.29–31 
Miniaturizing the process, Tian et al. and Poeckh et al. integrated silica in a capillary-
based microfluidic device. The silica was held in place using glass fibers, which also 
have an affinity for DNA since they are silica based.32,33 These surfaces were ignored 
during the analysis of their results and resulted in underestimating the total silica surface 
available in their systems. Efforts have also integrated silica particles into microfluidic 
polymer matrices to extract NAs.6 
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Commercially, true POC devices do not exist yet34 and kits similar to Qiagen’s 
require laboratory training, especially for the quantification of the final purified DNA. 
Fully integrated, stand alone, disposable POC devices that require minimal training to 
run, similar to pregnancy tests, have been published in literature.6,35 Sample lysis, NA 
purification, amplification, and detection were achieved in a microfluidic device. 
Commercially, the Cepheid GeneXpert can complete SPE extraction, NA amplification, 
and detection with the push of one button. It is close to a true POC device, however, it 
requires a high cost instrument to run the samples.36 Optimization of the lysis buffer is 
crucial for releasing all NAs from targeted cells in the sample. However, lysis buffer 
optimization doesn’t address the known limitation of silica SPEs: NA recovery is poor 
for dilute samples.  
All silica-based kits suffer from poor NA recovery for < 1 µg of NA. Qiagen 
columns require 5–10 µg of carrier DNA to ensure recovery of low copy plasmids.37 
Studies have repeatedly analyzed adsorption strength through surface saturation studies in 
a silica-limited reaction.11,13,33 For medical diagnostic applications, understanding the 
NA-limited case is more important as diagnosing infections often requires the detection 
of a single exogenous organism. Studies including Tian et al., Poeckh et al., and 
Kashkary et al. showed recovery with sub-microgram amounts of DNA. Silica was 
incorporated into a microfluidic device, and solutions with DNA were flowed 
though.32,33,38 Adsorption was measured by quantifying DNA depleted from the 
adsorption buffer, and recovery was quantified from DNA desorbed by the elution buffer. 
However, the use of < 0.1 mg silica meant that the amount of DNA was near the silica 
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surface saturation limit. Other studies have established recovery rates for a given amount 
of DNA for a set silica amount.39,40 Few studies, however, have explored DNA-silica 
interactions in a DNA-limited system. The poor recovery efficiency at low DNA 
concentrations results in a large LOD for low copy number applications. It can be 
counteracted with using larger volume samples, but this is not ideal for diagnostic 
applications, where often the smallest possible sample is desired to minimize discomfort 
for the patient. In addition, for miniaturized POC devices, small samples are often 
required to fit size-limited form factors to maintain portability.  
 Blood contains 2–6 µg human DNA per 100 µl,41 making it a high content 
sample for detecting human genetic markers. The large amount of human DNA in blood 
acts as a “carrier” for low concentration NAs from invading microorganisms. As a result, 
commercial protocols are often effective using blood as the input sample. However, 
blood is challenging in microfluidic POC devices for other reasons, including its 
relatively high viscosity and high protein content. This often results in clogging.  
Other biological fluids contain significantly less human DNA, including: urine 
(40–200 ng/ml),14 plasma (17 ng/ml),3 and cerebrospinal fluid (3 ng/ml),15 so these 
samples do not benefit from the carrier effect seen in blood. Urine is an appealing sample 
for POC devices as it is non-invasive. Applications exist, where infectious organisms are 
excreted through urine. For the human papillomavirus (HPV), precancerous legions 
produce 0 – 14,000 copies/ml in urine resulting in < 2 ng increase in total DNA.14,42,43 A 
common solution to this problem is to add exogenous DNA,37 but this adds cost via extra 
reagents and processing steps. The goal of this project is to improve recovery by 
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understanding the DNA-silica interaction at low concentrations of DNA in order to 
optimize recovery without adding complexity to the system. 
 
2.2 DNA-SILICA-CHAOTROPE INTERACTIONS 
 
DNA-silica interactions in the presence of a chaotrope are not completely 
understood.13,44 There are many components to this apparently simple system. Each part 
will be addressed separately as they pertain to this interaction. The exact mechanism of 
how a chaotrope increases DNA adsorption on a silica surface is not known, but the 
current hypothesis is that it is driven by dehydration effects.11 
 
2.2.1 SILICA 
 Silica is naturally occurring, but can also be artificially synthesized. It is a 
ceramic composed of SiO2 and has two possible surface groups. Silica surfaces can have 
single silanols (Q3) and/or geminal silanols (Q2) on the surface, as shown in Figure 3. The 
surface density and ratio of the two silanol groups (Q2:Q3) are dependent on how the 
silica was created.45 Thus, the experimentally measured isoelectric point (pI) of any given 
silica surface ranges from pI 1.5 to 3.6.46 Further experiments have determined the acid 
dissociation constants (pKa) of the silica surface are pH 4.5 and 8.5,47,48 and dissolution 
occurs at pH 8–10. Thus, the number of deprotonated surface silanols increases with 
increasing pH above the isoelectric point, resulting in a predominantly negative surface at 
a physiological pH of 7.0–7.4. This variability between silica surfaces with the varying 
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Q2:Q3 ratio generates a layer of complexity when comparing experiments conducted with 
silica from different sources. 
 
Figure 3. Surface groups on silica particle. The single silanol (Q3) is on the left and the 
geminal silanol (Q2) is on the right. 
 
2.2.2 DNA 
 DNA is well characterized as a double helix.49 Its pI is 5 due to the phosphate 
backbone groups that can be deprotonated.22 Double-stranded DNA (dsDNA) is held 
together through the hydrogen bonding between the nucleotides of complimentary 
sequences as shown in Figure 4. In acidic conditions (pH ≤ 2), DNA begins to fall apart 
through depurination of the nucleotides.50 This renders DNA strands unreadable. Similar 
to silica, DNA is negatively charged at physiological pH. The work in this thesis can also 
be applied to RNA due to its similar chemical composition to DNA. Previous 
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experiments by Boom et al. have demonstrated that DNA extraction and purification 
protocols using silica SPE to also be effective with RNA.23 
 
Figure 4. The chemical structure of DNA. The double strand is held together though 
hydrogen bonding between nucleotide pairs adenine-thymine and guanine-cytosine. The 
backbone can be deprotonated at the phosphate group. 
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2.2.3 CHAOTROPIC SALTS  
The chaotropic ability was first discovered by Franz Hofmeister in 1888. He 
ranked the ability of different monovalent ions to affect the solubility of egg white 
proteins in water.51 This list is now known as the Hofmeister series. Molecules that 
improved the solubility of proteins in water were designated as ‘chaotropes’, while 
molecules that decreased solubility were designated ‘kosmotropes.’ A partial Hofmeister 
series for cations is: 
CH6 N3+ > Li+ > Na+ > K+ > Rb+ > NH4+ 
Similarly for anions: 
SCN- > ClO4- > I- > NO3- > Br- > Cl- > F- 
The left side of the series consists of ions considered more chaotropic, while ions on the 
right are more kosmotropic. In general, increased charge delocalization generates the 
chaotropic ability.52 For example, guanidinium (CH6N3+) has resonance structure 
between the carbon atom and the nitrogens thereby delocalizing the positive charge and 
making it very chaotropic. By comparison, potassium has localized charge on a single 
atom, resulting in more kosmotropic behavior.  
 The difference in charge localization led to the hypothesis that water affinity 
determines chaotropic effects. Kim Collins published a paper demonstrating kosmotropes 
binding more strongly to water molecules compared to chaotropes.12 Additionally, these 
interactions effect multiple hydration shells around the ions. However, recent data 
demonstrate that both chaotropes and kosmotropes only effect the water structure in the 
first hydration shell.53 At high concentrations > 0.1 M, these ion specific interactions 
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dominate the bulk regardless.54 
 The specific ion effects make predicting and understanding the function of 
chaotropes and kosmotropes difficult. The most challenging hurdle to explain the 
Hofmeister series is the series reversal.55 The order of the Hofmeister series has been 
consistent throughout the experiments conducted, except for some instances when it 
reverses. The standard Hofmeister series is observed for protein solubility at pH higher 
than the protein pI. However, the opposite order is observed experimentally when the pH 
is lower than the protein pI.56 To complicate things, the order can be restored to the 
standard Hofmeister series by increasing the salt concentration.57 Efforts are ongoing to 
add quantum mechanics to current models to unify these paradoxical observations of the 
ionic behavior.58 
 
2.2.4 DNA-SILICA-CHAOTROPIC SALT  
 Knowledge of the phenomenon of a chaotrope facilitating improved adsorption of 
DNA onto a solid silica surface has existed for decades.23,59 An early application in 1979 
was to purify DNA from agarose gel. It bound DNA onto flint glass from ground 
scintillation vials.60 NaI was added as the chaotropic agent to promote adsorption. This 
method resulted in 90% DNA recovery and provided a faster, more convenient protocol 
to purify DNA compared the gold standard of 1979, acetone precipitation. The results 
were improved in 1989 by Boom et al. who designed a protocol to purify DNA and RNA 
from blood and urine in less than 1 hr.23 
 These results demonstrated the effectiveness of DNA purification using a silica 
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solid phase in the presence of a chaotropic agent. The underlying mechanism, however, 
was poorly understood, since both the DNA and the silica surface are negatively charged, 
which at first glance makes the interaction be counterintuitive due to electrostatic 
repulsion. Melzak et al. attempted to answer this question in 1996.11 They looked at 
adsorption of DNA in the presence of the chaotrope NaClO4 while varying the pH. Their 
results showed, as expected, that binding capacity increased with increasing 
concentration of NaClO4. They also showed that binding capacity peaked at low pH. It 
was stable from pH 3.5 to 6.5 and then began to decrease. This result is consistent with 
the fact the electrostatic repulsion increases with pH and the forces that promote 
adsorption are finally overcome by negative-negative repulsion. Melzak et al. 
hypothesized that the presence of a chaotrope dehydrates the DNA, which then promotes 
hydrogen bonding between the DNA and the silica surface,11 leading to the following 
reaction: 
 
DNA (hydrated) + silica (hydrated) + counterions ⇋ neutral DNA-silica complex + water 
 
This hypothesis was based on observations of proteins adsorbing onto hydrophobic 
surfaces, which may not be directly applicable to DNA-silica interactions.61 However, 
this has remained the predominantly accepted theory.  
 The results, however, are not relevant for medical diagnostic applications. In 
diagnostic devices, the DNA will often be the limiting reagent, and as mentioned 
previously, samples may contain < 100 ng/ml of DNA.14,15 Melzak et al. assessed DNA 
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adsorption by quantifying unbound DNA subsequent adsorption to determine binding 
capacity with at least 12 µg DNA.11 Similar amounts of DNA were used by Vandeventer 
et al. in 2012 to conduct bulk depletion experiments on silica with quartz crystal 
microbalance.13 Qiagen, who has commercialized silica extraction columns, requires 
samples with at least 5 µg of total DNA.37 Tian et al. and Poeckh et al. conducted 
adsorption and elution studies with samples containing 100–300 ng/ml32 and 200 ng/ml – 
1 µg/ml33 prepurified DNA, respectively. Although this is an improvement, their devices 
contained 0.2–0.3 mg of packed silica particles in a polyethylene sleeve with an inside 
diameter of 0.78 mm, making them susceptible to clogging from crude patient samples. 
Additionally, the silica particles were held in place with glass fibers, which contributed 
additional silica surface area for the DNA to adsorb to. However, this area was not 
included in their calculations of total silica surface area. 
 The current inability to capture and release low amounts of DNA efficiently still 
limits some applications for this technology. DNA purification using silica has been used 
in the design of rapid, portable diagnostic devices. The widespread use of such devices 
could help accelerate the implementation of personalized medicine, and such devices 
would be POC, and potentially require no lab work to operate. However, to create a 
universal POC diagnostic independent of NA target, the dynamic range of silica SPE 
devices needs to be expanded for DNA-limited applications. 	  
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2.3 DNA QUANTIFICATION 
 
2.3.1 PCR 
 Initial studies done by Melzak et al. were done through bulk depletion studies 
where UV-vis spectrophotometry was used to quantify DNA. Unfortunately, it is difficult 
to achieve a limit of detection (LOD) lower than 0.2 µg/ml.62 So for this thesis, qPCR 
was used. PCR was first published by Dr. Kary Mullis in 1987,63 which earned him the 
1993 Nobel Prize in Chemistry. The technique used cellular enzymes to replicate DNA. 
Specifically, it uses DNA polymerase to duplicate any desired locus of a DNA strand.  
The polymerase generates DNA sequences based on an already existing strand. 
The general steps of PCR are displayed in Figure 5. PCR begins by denaturing dsDNA 
into single-stranded DNA (ssDNA) by heating to 95 °C. The temperature is lowered such 
that primers anneal to the ssDNA. These are short nucleotide sequences that act as 
starting points for the polymerase to initiate replication, and are located to the 5’ side of 
the desired locus. Due to the primers’ complimentary nature, it allows the polymerase to 
extend the primer from 5’ to 3’ by adding complementary nucleotides using the ssDNA 
sequence as a template. The specific annealing temperature depends on the primer 
sequences and the primer pair must be designed to have similar melting temperatures 
(Tm). Once the primers have annealed, the reaction’s temperature is raised to increase the 
efficiency of elongation by the polymerase. This entire process is then repeated by 
heating to 95 °C to begin a new cycle. Each PCR cycle should double the amount of 
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DNA loci in a reaction. This allows the identification of even one DNA strand in a given 
reaction. 
 
Figure 5. Principles of PCR. PCR is used to replicate DNA using enzymes available in 
cells. dsDNA is heated to 95 °C to denature it into its two ssDNA strands. The sample is 
then cooled to the Tm of the primers, in this case 65 °C, so that they anneal onto the 
ssDNA. The primers are located to the 5’ end of the target locus that one wants to 
replicate. The DNA polymerase then attaches at the locus of the primers to initiate 
elongation and the temperature is raised to 72 °C to optimize the efficacy of the 
polymerase. Once elongation is complete, the cycle can start again by denaturing the new 
dsDNA. Each cycle doubles the number of target DNA loci allowing for the potential 
detection of even one copy in the original sample. 
DNA amplification through PCR in itself is not quantitative. Advances have been 
made where DNA amounts can be tracked after each cycle. In these systems, DNA is 
quantified using fluorescent dyes. After a certain number of cycles, the fluorescence can 
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be detected, and increases until all nucleotides are consumed by the reaction. This 
generates ΔRn vs. cycle plot, as shown in Figure 6, that has an initial linear region 
followed by leveling off to saturation. The cycle number refers to the number of PCR 
cycles the sample has completed and the ΔRn is the difference between the relative 
fluorescence, Rn, at a given cycle and the initial baseline fluorescence. Rn is the relative 
fluorescence normalized to a passive background dye, usually carboxy-X-rhodamine 
(ROX). Using these plots, a threshold is determined by picking a ΔRn value that 
intersects every sample curve in the linear regime and a sample’s intercept with the  
Figure 6. ΔRn vs. cycle plot. PCR can be quantitative by using samples of known 
amounts of DNA similar to those plotted above. The fluorescence of each sample is 
measured after each PCR cycle forming the plot. ΔRn is the difference between the Rn at 
a given cycle and the initial background, where Rn is the fluorescence normalized to the 
fluorescence of a passive background dye, usually ROX. Using this plot, a ΔRn value is 
chosen such that is resides in the linear region of all samples called the threshold. A 
sample’s corresponding cycle number at the threshold is called the CT value. Sample CT 
values are compared to the CT values of the standards to determine a sample’s initial 
DNA amount. 
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threshold is known as the critical threshold (CT) value. Samples run on the same plate are 
directly comparable, and ideally, a decade increase in fluorescence or initial DNA 
amount should be ~ 3.3 cycles. 
PCR can become quantitative by running samples with known amounts of DNA, 
called standards. Such samples are shown in Figure 6. A no template control (NTC) is 
also run to establish the background noise level. The CT values corresponding to the 	
standards form a basis on which other samples are compared to. This is used to calculate 
the initial DNA amount in the samples. 
 The PCR reactions used in this thesis will use a Taqman probe instead of an 
intercalating dye, such as Sybr Green. This adds extra specificity, as the fluorescence 
generated is locus specific. The Taqman probe, as shown in Figure 7, is a short nucleic 
sequence that anneals at the desired locus.64 It has a 6-carboxyfluorescein (6-FAM) 
attached to the 5’ end and a quencher attached at the 3’ end.65 The Taqman as constituted 
does not fluoresce due to the close proximity of the quencher to the 6-FAM. During the 
elongation step in PCR, the DNA polymerase disassembles the probe into individual 
nucleotides, thereby separating the quencher from the fluorescent tag resulting in a signal. 
The resulting fluorescence doubles with each additional cycle. 
 
2.3.2 ETHANOL PRECIPITATION 
Using PCR is an advantage to probe at the DNA-silica interaction with dilute 
samples, but it can be sensitive to samples with high ionic strength. This can interfere 
with the efficacy of the DNA polymerase resulting in inconsistent results and sometime 
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Figure 7. Taqman probe generic protocol. The Taqman probe is a locus specific 
fluorescent dye. A complimentary sequence to the target locus is designed with a 
fluorescent tag on the 5’ end and a quencher on the 3’ end. This probe doesn’t inherently 
fluoresce due to the close proximity of the quencher to the fluorescent tag. As samples 
run through the PCR cycle as explained in Figure 5, the probe is broken apart during the 
elongation step separating the fluorescent tag from the quencher. As a result, the qPCR 
can detect the fluorescent tag. In ideal conditions, this generates a fluorescent tag for 
every copy of target DNA locus. 
inhibiting elongation completely.24 Thus, samples will need to be in low salt solution not 
to interfere with PCR reactions. After collecting the samples, DNA will be precipitated 
out of solution and then resuspended in either Qiagen Buffer EB (10 mM Tris-Cl pH 8.5) 
or 1x TE (10 mM Tris-Cl, 1 mM EDTA pH 8.0) via ethanol precipitation.  
Ethanol precipitation is the golden standard for purifying DNA, and is standard 
protocol in biology laboratories. There are many variations, but the basic principles are 
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the same. Salt is added to a sample with DNA to neutralize the phosphate ions on the 
DNA backbone. Usually NaCl, CH3CO2Na, NH4CH3CO2, or LiCl are used and glycogen 
is sometimes added to improve precipitation.7 After vortexing, an alcohol is added. This 
original protocol tripled the volume with ethanol, resulting in naming it ethanol 
precipitation. However, isopropanol, 1-butanol, 1-decanol, or any other alcohol can be 
used. The principle is to lower the dielectric constant of the solution to promote 
precipitation.66 Choosing the proper alcohol depends on a) the solvent of the original 
DNA sample and b) chemicals added to the sample. One part of aqueous solution 
containing DNA can be precipitated by adding 2 parts of ethanol or 1 part isopropanol, 
whereas precipitation from blood sometimes requires 1-butanol. The mixture is allowed 
to equilibrate and sometimes placed in -20 °C overnight to promote additional 
precipitation at the cost of potentially precipitating unwanted components.7 It is 
subsequently vortexed in the microcentrifuge to form a DNA pellet. The pellet is then 
washed twice with 70% ethanol before it is air-dried, and resuspended in a low salt 
solution. This guarantees DNA is replicated efficiently in PCR. 
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CHAPTER 3 
CASE STUDY: DIAGNOSING SEPSIS IN MICROSCALE SYSTEMS 
 
3.1 BACKGROUND 
 
 This thesis began as a study to design a rapid POC diagnostic device for sepsis. 
Sepsis is caused by the infection of the blood by a foreign organism.67 The blood can 
become infected in a number of ways, but hospital-acquired infections in already 
immunocompromised patients are especially dangerous. Septic shock has a mortality rate 
of 42%68 and sepsis accounts for 1 in every 2–3 deaths69 in hospitals. The greatest 
impediment to decreasing the mortality rate is the time required for determining the 
diagnosis. The current gold standard is to draw blood, and culture it to identify the cause 
of the infection. Blood cultures usually take 24–72 hrs for readable results.70 Blood 
samples from symptomatic patients may contain as little as 1 colony-forming unit (CFU) 
per ml.71,72 Additionally, the causative organism in sepsis may be gram-positive bacteria, 
gram-negative bacteria, fungi, or viruses, which is not discernable from observable 
symptoms, making timely and appropriate treatment difficult.73 
 A POC NA test could reduce the time to diagnosis, while also providing 
information about the causative organism. Since the patient sample in sepsis diagnosis is 
blood, NA extraction and purification is required before NA amplification. Thus, the 
integration of an SPE column to extract the NA from the crude sample is critical to an 
integrated device design.  
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Reaching the 1 CFU/ml detection limit requires NA amplification like PCR.1 
Organism specific primers and probes could be designed, and a multiplexed device could 
be envisioned.74 A simple version of such a device would lyse a patient sample, purify 
the DNA, and determine a yes/no answer for the presence of gram-positive bacteria, 
gram-negative bacteria, or fungi. It is estimated that this strategy could reduce the time to 
answer to at most 4 hrs.23,75,76 Such a device could potentially also be microorganism 
independent, as compared to current blood cultures that are stratified by class of 
organism,72 since PCR primers and probes could be designed that allow for the 
identification of multiple microorganisms, such as gram-positive or gram-negative DNA.  
 For the study described here, Escherichia coli was used as a model gram-negative 
bacterium. A dual detection strategy was used in this prototype design. An assay 
designed by the Hauser Laboratory at Beth Israel Deaconess Medical Center that was 
shown to discriminate between inflammation and septic shock was chosen as a basis for 
the prototype.77 Systemic inflammatory response syndrome (SIRS) presents clinically 
similar to sepsis with elevated pressure, elevated temperature, elevated heart rate, and 
elevated while blood cell count, and is often caused from a traumatic event that leads to a 
compromised immune system from open wounds.78 As a result, it is difficult to 
differentiate if SIRS or sepsis is the cause of inflammation at a traumatic site. 
Additionally, it is vital to diagnose the presence of sepsis due to its high mortality rate 
and the time required for diagnosis. The Hauser Laboratory demonstrated that 
mitochondrial DNA (mtDNA) concentration increases in blood as a response to traumatic 
inflammation.79 Thus, mtDNA can be used as a biomarker for SIRS, and if multiplexed 
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with gram-negative bacterium detection can produce a device that can determine if 
clinical signs of inflammation are due to a) SIRS, b) sepsis, c) both, or d) neither.  
 The final design was to 1) lyse a patient sample to extract DNA from all cells,  
2) purify the DNA from other biomolecules, and 3) quantify E. coli and mtDNA amounts 
in one, multiplexed PCR reaction. The goal was to streamline the entire process and 
minimize the amount of steps and components without sacrificing the sensitivity and 
specificity of PCR in a microfluidic device. The replication sites in E. coli and mtDNA 
were chosen such that they were unique and the primers and probe sets would not 
interfere with each other. But, the potential existed that multiplexing would produce 
additional background signal, and parallel PCR reactions would be run as an alternative 
using a single clinical sample. In addition to make this test viable, the baseline 
concentration of mtDNA in the bloodstream for non-SIRS patients would need to be 
established. 
We first sought to optimize the cell lysis and qPCR protocol in tube reactions 
before designing and optimizing a microfluidic device. Demonstrating the ability to lyse 
and quantify E. coli bacterial DNA and human mtDNA in a multiplexed reaction was the 
first step of a POC diagnostic development process.  
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3.2 LYSIS EFFICIENCY OF BOOM D 
 
3.2.1 METHODS AND MATERIALS 
 The first step was to determine the lysis efficiency of a blood lysis buffer 
optimized for use in microchannels. The previously published lysis buffer was developed 
in our laboratory and nicknamed ‘Boom D’ (6 M GuSCN, 100 mM MOPS pH 7,  
18.5 mM N-lauroylsarcosine, 100 mM 2-mercaptoethanol).80 One Shot TOP10 
chemically competent E. coli (Thermo Fisher Scientific, Waltham, MA, USA) was used 
as the model test organism. The PCR primers and probes developed by the Hauser 
Laboratory were used.79 PCR results were quantified based on standards made from NEB 
K12 E. coli purified DNA (New England Biolabs, Ipswich, MA, USA), and the initial 
number of E. coli in each sample were determined by plating overnight on agar plates.  
 Frozen stock of E. coli transformed with pGEM-T Easy vectors (Promega, 
Madison, WI, USA) carrying the anti-ampicillin gene was streaked onto agar plates with 
1 µg/ml ampicillin and incubated overnight at 37 °C. Single colonies were then 
inoculated into lysogeny broth (LB) (Millipore, Billerica, MA, USA) with 1 µg/ml 
ampicillin. The bacteria were grown until the OD600 of the solution was between 0.2–1 
to ensure they were in log growth phase. An OD value of 1 corresponded to 109 CFU/ml. 
Serial 10-fold dilutions were made down to 0.1 CFU/µl and 100 µl of the smallest two 
dilutions were plated to verify the E. coli count. Triplicate samples of 50 µl 0, 105,  
106 CFU/ml E. coli were collected in 1.7 ml microcentrifuge tubes. The samples were 
spun down in a microcentrifuge at max speed, and the LB was replaced with 100 µl 
	27 
human blood (SeraCare Life Sciences, Milford, MA, USA). A parallel set of blood only 
samples were also lysed to establish the LOD of the reaction and quantify potential 
bacteria in the SeraCare blood. All blood samples, with and without E. coli, had 233 µl 
Boom D, 42 µl of 5 M NaCl, and 5 µl of 15 mg/ml glycogen (Thermo Fisher Scientific, 
Waltham, MA, USA) added. The glycogen and NaCl were required for the subsequent 
ethanol precipitation the DNA from solution. This solution was vortexed and incubated at 
ambient conditions for 20 min to allow the Boom D buffer to lyse the sample.  
Following lysis, 162 µl of 1-butanol was added to the tube, and it was vortexed 
again. The solution was spun in a microcentrifuge at max speed for 15 min and the 
supernatant was decanted, and replaced with 1 ml 70% ethanol. After a 10 min spin, the 
supernatant was again decanted, and replaced with 70% ethanol. The pellet was finally 
dried after a final spin with an open top tube and finally resuspended in 50 µl TE. 
 The resuspended samples were quantified using the 7300 real-time PCR machine 
(Applied Biosystems, Foster City, CA, USA). The forward primer was 5’–CGT CAG 
CTC GTG TTG TGA AA–3’, the reverse primer was 5’–GGC AGT CTC CTT TGA 
GTT CC–3’, and the Taqman probe was 5’–AGG ATA AG GGT TGC GCT CGT T–3’ 
with the 5’-end labeled with 6-FAM and the 3’-end with an minor groove binder non-
fluorescent quencher (MGBNFQ). The primers were purchased from Integrated DNA 
Technologies (IDT, Coralville, IA, USA) and the Taqman probe from Life Technologies 
(Carlsbad, CA, USA). Each PCR 25 µl reaction consisted of 10.5 µl water, 5 µl sample, 
2.5 µl 10x Brilliant2 buffer, 1.5 µl of 10 µM of each primer, 1.5 µl of 50 mM MgCl2, 1 µl 
20 mΜ dNTP, 0.75 µl of 1:99 diluted 1 mM Rox reference dye, 0.5 µl of 10 µM Taqman 
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probe, and 0.25 µl SureStart Taq DNA polymerase. PCR-specific components were 
purchased from Agilent Technologies (Santa Clara, CA, USA). Known amounts of K12 
were run in parallel as quantitation standards. The temperature profile of the PCR run 
began with 15 min at 95 °C to initiate the polymerase, followed by 40 cycles at 30 sec at 
95 °C to denature, 30 sec at 63 °C to anneal, and 30 sec at 72 °C to extend. The thermal 
profile was determined by preliminary work in the Hauser lab to minimize nonspecific 
amplification.79 
 
3.2.2 RESULTS 
 The percent of E. coli recovered from the test samples is shown in Figure 8. 
Plating of the E. coli standard dilutions determined that the E. coli dilutions contained  
1.7 times the expected E. coli amount, thus 10 and 100 CFU/ml dilutions actually had  
17 and 170 CFU/ml. The data were corrected for this underestimation. Recovery overall 
was poor. Recovery was less than 40%, except in the case where the calculated recovery 
exceeded 100%. It is possible, but unlikely that the commercially obtained blood samples 
contained pre-existing E. coli that resulted in recovery of greater than 100%, since the 
LOD established by blood only samples was 0.05%. It is more likely that contaminating 
DNA came from other sources. 
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Figure 8. Percent recovery of lysed E. coli in blood and LB broth using tube based 
extractions. Known amounts of E. coli were added to LB broth and blood. Samples were 
lysed to extract, purify, and quantify E. coli amounts. Error bars are one standard 
deviation from the mean. (n = 3) 
 
3.2.3 DISCUSSION 
 There are three problems with the initial results that merit additional investigation 
and optimization: 1) low DNA recoveries, 2) large error bars, and 3) high LOD. It was 
difficult to determine which part of the protocol, lysis, ethanol precipitation of DNA, or 
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qPCR protocol, was responsible for the inconsistent results. Low recoveries could be 
related to inefficient lysis, poor DNA precipitation, and/or poorly designed PCR primers 
and probes resulting in inefficient replication. High error bars and a high LOD of  
7,800 CFU/ml indicated that the protocol required optimization for the specific 
application of lysing E. coli. We updated the PCR protocol and redesigned the primers 
and probes, generated a proper set of PCR standards, and optimized the ethanol 
precipitation of DNA, and optimized the Boom D lysis to detect mtDNA and E. coli in 
blood. We first began with the PCR components and genomic standards to increase the 
DNA signal and lower the LOD. 
 
3.3 REDESIGN AND OPTIMIZATION OF PCR 
 
3.3.1 E. COLI/mtDNA PRIMERS AND PROBES 
 The detection components were first redesigned. PCR primers and probes have 
many rules for successful oligonucleotides, which will be covered, but it is important to 
note the National Center for Biotechnology Information’s (NCBI) Basic Local Alignment 
Search Tool (BLAST), ApE (a plasmid editor), and IDT’s online OligoAnalyzer tool are 
crucial when assessing the potential efficacy of proposed primers and probes. The E. coli 
and mtDNA probes were labeled with FAM and VIC respectively to potentially multiplex 
the two PCR reactions. 
	31 
 We searched for loci within the conserved 16S gene of E. coli. All potential 
primer and probe sequences were searched in BLAST to ensure uniqueness. The 16S 
gene is present in all bacteria and many hits were expected. However, it was important 
that the E. coli sequences chosen were not present in human DNA to limit false positives 
in any future device. Similarly, the cytochrome B (cytoB) gene was chosen as the locus 
for the detection of mtDNA, and potential sequences were crosschecked against bacterial 
genomes. 
 The primers were chosen to be about 20 nucleotides long and with Tm near 60 °C. 
Primer pair (forward and reverse) sets had the same Tm. This ensures both primers anneal 
at the same time. The probe should have a slightly higher Tm to ensure it anneals when 
the primers do. The G-C content of all nucleotides should range 30–80%, and the probe 
cannot have a G on the 5’ end. Additionally, the primers should have at most 2 Gs and/or 
Cs in the five nucleotides on the 3’ end to prevent non-specific replication. The G-C 
content and predicted Tm of each sequence can be evaluated using the OligoAnalyzer. It 
is also crucial to crosscheck the sequences against each other to determine if they contain 
complimentary regions. If the primers and probe contain large complimentary regions, 
more than 4 sequential nucleotides, it is possible the polymerase will extend them, 
resulting in inefficient DNA replication. Thus, it is suggested that repeated nucleotide 
regions are to be avoided as well as large regions of only Cs or Gs. 
The final primers and probes that were designed for E. coli and cytoB are in  
Table 1. The sets were initially examined using the original PCR mix formula as in 
section 3.2.2. Jurkat cell human genomic DNA (Thermo Fisher Scientific, Waltham, MA, 
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USA) and E. coli K12 genomic DNA (ATCC, Manassas, VA, USA) were used as 
standards. The PCR mix was further optimized to minimize the NTC signal to lower the 
LOD. All tested conditions, including other primer and probe sequences, PCR reaction 
mixtures, and temperature profiles, are in Appendix A The final chosen mix for E. coli 
consisted of 9.5 µl water, 5 µl sample, 2.5 µl Core SureStart buffer, 1.5 µl of 50 mM 
MgCl2, 1.5 µl of 4 µM forward primer, 1.5 µl of 4 µM reverse primer, 1 µl of 20 mM 
dNTP, 1 µl of 100 mM dithiothreitol (DTT), 0.75 µl of 1:99 dilute 1 mM Rox reference 
dye, 0.5 µl of 10 µM Taqman probe, and 0.25 µl SureStart Taq DNA polymerase. The 
temperature profile used was 15 min at 95 °C, followed by 40 cycles of 30 sec at 95 °C 
for denaturing, 5 sec at 65 °C for annealing and 30 sec at 72 °C for elongation. During 
the process of optimizing the cytoB primers and probe, an Applied Biosystems 7500 real-
time PCR machine (Applied Biosystems, Foster City, CA, USA) was purchased and 
implemented. As a consequence, the ROX reference dye had to be diluted 1:999 instead 
of 1:99, due to the improved sensitivity of the machine. Otherwise, the same PCR 
protocol was used as for E. Coli and the same temperature profile. 
E. coli PCR sequences Tm (°C) 
FAM probe 5'–TTG CGC TCGT TGC GGG ACT T–3' 63 
forward primer 5' –ACC GCT GGC AAC AAA GGA TA–3' 57 
reverse primer 5'–AGA ATG TGC CTT CGG GAC C–3' 57 
   cytoB PCR sequences Tm (°C) 
VIC probe 5'–ACG CCC TCG GCT TAC TTC TC–3'  59 
forward primer 5'–CCT ATT CTT GCA CGA AAC GGG AT–3' 57 
reverse primer 5'–GGT ATA ATT GTC TGG GTC GCC T–3'  57 
 
Table 1. Designed PCR primers and probes for E. coli and cytoB along with their 
melting temperature.  
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3.3.2 λ-PHAGE PRIMERS AND PROBE 
In order to also have a robust DNA assay to test our NA extraction and 
purification materials, we designed an assay using readily available and highly 
characterized λ-DNA. This assay was used as a control assay throughout the work in this 
thesis. It is not related to the sepsis assay directly.  
The same method as in Section 3.3.1 was used for this process. The final 
nucleotide sequences are in Table 2, and the other candidate sequences are in Appendix 
A. Similar to the E. coli probe, the λ-DNA probe was labeled with 6-FAM and quenched 
with an MGBNFQ. Pre-purified λ-DNA was purchase from NEB (Ipswich, MA, USA) to 
be used as standards. 
λ-DNA PCR sequences Tm (°C) 
FAM probe 5'–AGG TGC TAC GGC GGC AGA GT–3'  64 
forward primer 5'–GTG GAA TGA ACA ATG GAA GTC AAC AA–3'  56 
reverse primer 5'–GGC AGA GTC ATA AAG CAC CTC ATT A–3'  57 
 
Table 2. Designed PCR primers and probed for λ-DNA along with their melting 
temperatures. 
 
3.3.3 MAKING STANDARDS 
 The 16s locus was cloned to be used as a DNA quantification standard in qPCR. It 
was inserted into pGEM-T Easy vectors, replicated, purified, and quantified via UV-vis 
spectrophotometry. Knowing the length of the 16S insert, the vector, and the final 
concentration of purified 16S-inserted vectors, one can calculate the concentration of 
copies in the final solution and generate serial dilutions to use as standards in qPCR.  
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16S and pGEM-T Easy Vector Digestion 
 The process began by amplifying the 16S gene from prepurified K12 E. coli DNA 
from ATCC. Cloning primers were chosen such that the whole gene was replicated, 
including the PCR locus and primer locations discussed in Section 3.3. The primers were 
complimentary to the 20 base pairs in the E. coli genome just outside the 16S gene. The 
nucleotide sequence for SpeI (ACTAGT) was incorporated at the 5’-end of the forward 
cloning primer, and the sequence for AatII (GACGTC) was attached to the 5’-end of the 
reverse primer. The forward primer was 5’–GCT AAC TAG TAT TGA ACG CTG GCG 
GCA GGC–3’ and the reverse primer was 5’–GAT TGA CGT CTT CTT TAA GGT 
AAG GAG GTG ATC AA–3'. SpeI and AatII restriction enzymes were chosen since the 
pGEM-T Easy vectors contain both enzyme sites. These enzymes create sticky ends that 
allow for the insertion of the 16S gene into the vector as shown in Figure 9. The 16S gene 
was replicated using Phusion high-fidelity DNA polymerase (NEB, Ipswich, MA, USA) 
in a 50 µl reaction. The mixture contained 5 µl 5x Phusion HF Buffer, 5 µl DNA, 2 µl of 
10 mM forward primer, 2 µl of 10 mM reverse primer, 2 µl of 50 mM MgCl2, 1 µl 
dimethyl sulfoxide (DMSO), 0.5 µl Phusion HF polymerase, 0.5 µl of 25 mM dNTP, and 
31 µl water. The PCR reaction was heated at 95 °C for 30 sec and then cycled 10 sec at 
95 °C followed by 1 min at 72 °C 40 times. Phusion polymerase was used instead of Taq 
polymerase, since it was imperative that replication errors were minimized; this enzyme 
is 50 times more accurate than the standard Taq polymerase.81 
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Figure 9. 16S insertion into pGEM-T Easy vector. Sticky ends created by AatII and SpeI 
restriction enzymes were used to insert the 16S gene. The pGEM-T Easy vector also has 
a blunt ZraI restriction enzyme site, which was used to linearize the vector and the 
ampicillin resistance gene Ampr. 
 After replication, the DNA was purified via phenol:chloroform extraction. NaCl 
was added to a final concentration of 0.3 M followed by doubling the volume with  
1:1 phenol:chloroform. The sample was vortexed, and spun down at max speed in a 
microcentrifuge for 15 min. The aqueous layer was separated from the organic layer, and 
the process was repeated once more. The DNA was then ethanol precipitated from the 
final collected aqueous layer by adding 5 µl of 15 mg/ml glycogen and doubling the 
volume with isopropanol. The sample was spun for 15 min for the DNA to form a DNA 
pellet. The pellet was then washed twice with 70% ethanol, resuspended in 1x TE, and 
quantified via UV-vis spectrophotometry. Purified DNA should have an A260/ A230 
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peak ratio of at least 2.62 DNA purification was necessary to remove PCR components 
that would interfere with the subsequence restriction enzyme step. 
 The DNA was digested with SpeI and AatII from NEB (Ipswich, MA, USA). The 
protocol provided by NEB was used and scaled up as appropriate. For a 20 µl reaction 
with up to 1 µg DNA, 5 µl of DNA were combined with 2 µl NEB buffer 4, 2 µl of  
1 mg/ml BSA, 1 µl of 10,000 units/ml SpeI, 1 µl of 20,000 units/ml AatII, and 9 µl water. 
The solutions were then incubated at 37 °C for 1 hr for every 1 µg of DNA. The 
amplified 16S loci were digested in parallel with pGEM-T Easy vectors.  
 Once digestion was complete, the target loci were further purified using get 
extraction. The digested DNA was first run on 1% agarose gels. The gel was made by 
microwaving 1 g agarose in 100 ml TAE buffer (40 mM Tris-acetate, 1 mM EDTA, pH 
8.3) to dissolve the agarose. Once cooled, 6 µl of ethidium bromide was added, and the 
agarose was poured into the desired mold. The gel was submerged in TAE buffer after 
the gel solidified. The digested DNA was loaded into the gel with 3% ficoll blue dye and 
a 1 kb ladder (NEB, Ipswich, MA, USA) was run in parallel on the same gel. The gel was 
run at 85 V for 1.5 hrs. As expected, the digested 16S formed a bright band at 1 kb and 
the digested plasmid formed a band at 3 kb. The bands were cut out of the gel using a 
razor and placed into 1.7 ml microcentrifuge tubes. The two bands were purified using 
Qiagen gel extraction kits (Qiagen, Hilden, Germany). Both purified vectors and purified 
16S loci were further purified by ethanol precipitation to remove leftover chaotropic salt 
from the Qiagen kits. Again, 5 µl of 15 mg/ml glycogen and NaCl were added to a final 
concentration of 0.3 M. The volume was then doubled with isopropanol, and the samples 
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were spun down for 15 min. The resulting pellets were washed twice with 70% ethanol, 
and resuspended with 1x TE.  
 
DNA ligation 
 The digested 16S and pGEM-T Easy vector were ligated. T4 DNA ligase (NEB, 
Ipswich, MA, USA) was used with the protocol provided by NEB. In a 20 µl reaction,  
2 µl 10x T4 ligase buffer (NEB, Ipswich, MA, USA), 1 µl of 400,000 units/ml T4 ligase, 
5 µl of the digested vectors, 5 µl of the digester 16S loci, and 7 µl water were mixed and 
incubated at room temperature overnight. The ligated samples were again run on a 1% 
agarose gel, gel extracted, and ethanol precipitated.  
 
Transformation and vector isolation 
 The ligated 16S plasmids were transformed into TOP10 chemically competent  
E. coli cells. The E. coli will replicate the plasmids that can then be purified in large 
amounts. The protocol provided with the TOP10 E. coli was used. The E. coli was 
thawed on ice, and 5 µl of the ligated plasmid were added. The cells were incubated on 
ice for 5 min, and then spread on LB agar plates with 1 µg/ml ampicillin. The plates were 
then incubated at 37 °C overnight or until the formation of colonies. Theoretically, each 
colony on a plate is produced by a single E. coli bacterium and thus should contain at 
least one plasmid. Six individual colonies were chosen at random, and streaked on a new 
plate to further isolate individual plasmids from the transformation step. This step is not 
vital, but it will increase the chances of isolating and sequencing a single plasmid. From 
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the six new streaks, three were chosen and single colonies were inoculated in LB broth to 
isolate their plasmids. The Qiagen Miniprep kit was used to purify plasmids from E. coli 
harvested when they achieved log-phase growth, as in Section 3.2. Half of each sample 
was sent for sequencing with the associate primers to Genewiz (Cambridge, MA, USA).  
 
Sequencing 
During BLAST, we noticed that the 16S gene is repeated in the E. coli genome. 
The complete 16S gene in E. coli is compromised of 7 subunits named rrsA, rrsB, rrsC, 
rrsD, rrsE, rrsG, and rrsH. Their locations are displayed in Figure 10 based on the K12  
E. coli genome (accession number U00096.2). Comparing the 1,542 bp of each subunit, 
up to 10 base pairs differed. Unfortunately, nucleotide differences in rrsH are in the 
primer region from Section 3.2. Thus this generated two concerns: 1) do the designed 
primers and Taqman probe designed in Section 3.2 replicate at the same rate even with 
the nucleotide differences in rrsH and 2) are the samples sent to sequencing pure in terms 
of subunits or a mixture. From the three sequencing samples sent to Genewiz, two came 
back as matches. One was inconclusive, the second was rrsC, and the third was either 
rrsB or rrsE (these subunits are identical and will be referred to as rrsB for the remainder 
of the thesis).  
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Figure 10. Location of 16S subunits in the E. coli genome based on K12 E. coli 
accession no. U00096.3.  
A portion of the rrsB and rrsC isolates was digested with SpeI and AatII to 
confirm purity and plasmid size as shown in Figure 11. The length of the pGEM-T Easy 
vector was 3.0 kb and the length of the 16S subunit was 1.5 kb. However, the 16S 
subunits contained an AatII restriction enzyme site within the gene, but outside the qPCR 
locus discussed in Section 3.2. So although this was unnoticed, the plasmid could still be 
used as a PCR standard. As a result, the expected length of the 16S subunit was 1.2 kb. 
These expected lengths were confirmed by running the digested samples on a 1% agarose 
gel with 1 kb and 100 bp ladders from NEB (Ipswich, MA, USA) similar to the protocol 
in Section 3.4.1. The rrsB-pGEM-T Easy vector was chosen for use in future 
experiments. 
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Figure 11. pGEM-T Easy vectors with rrsB or rrsC inserts digested with SpeII and AatI. 
Samples resulted into two segments: a 3.0 kb segment of the pGEM-T Easy vector, and a 
1.2 kb segment from rrsB or rrsC. 
 
Vector vs. genome 
The vector was used to quantify genomic DNA, so the final step was to linearize 
the rrsB-pGEM-T Easy vector. Circular DNA replicates at a faster rate than linear DNA, 
so it needs to be cut. The pGEM-T Easy vector contains a nucleotide sequence specific 
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for a ZraI restriction enzyme blunt cut. Again, it was cut using the protocol provided by 
ZraI. For a 20 µl reaction, 2 µl NEB Buffer 4, 2 µl ZraI, 5 µl rrsB-pGEM-T Easy vector, 
and 11 µl water were incubated overnight at 37 °C. The linearized DNA was then 
purified by phenol:chloroform extraction and ethanol precipitation as in Section 3.4.1. 
The concentration of purified DNA was finally quantified via UV-vis spectrophotometry. 
The molecular weight of the DNA can be calculated from its length, and this can be used 
to convert the concentration of the purified plasmid sample to copies per unit volume. 
Achieving this allowed us to examine if all seven 16S subunits replicated with the same 
efficiency with the qPCR primers and probe designed in Section 3.2.1. 
 
Figure 12. K12 E. coli genomic DNA vs. rrsB-pGEM-T Easy vector standards. 
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 The purified genomic DNA was compared to the purified, linearized plasmids to 
establish that they were comparable. Both were converted to concentrations of copies per 
volume and serial dilutions of 1, 10, 102, 103, 104, 105 of E. coli K12 genomes/µl were 
compared to 7, 7·10, 7·102, 7·103, 7·104, 7·105 of rrsB-pGEM-T Easy vectors/µl. All 
samples were run using the PCR protocol from Section 3.2 and the results are shown in 
Figure 12. Corresponding orders of magnitude overlap as expected, i.e. 105 genomic 
copies with 7·105 rrsB copies, 104 genomic copies with 7·104 rrsB copies, etc. Thus, the 
rrsH subunit in genomic DNA replicates with the same efficiency as the other 16S 
subunits. 
 
3.4 LYSIS EFFICIENCY REVISITED 
 
 A quantification method for E. coli was established. The next step was to design 
and optimize the lysis protocol. The initial scope of this project was to detect bacteria 
from blood, so commercial kits sold to specifically lyse blood were examined. The 
QIAmp DNA Blood Mini Kit (Qiagen, Hilden, Germany), DNAzol, and DNAzol BD 
(Thermo Fisher Scientific, Waltham, MA, USA), were chosen. In addition, lysis with 
lysozyme (Thermo Fisher Scientific, Waltham, MA, USA) followed by ethanol 
precipitation was added as a lysis control protocol, since lysozyme is known to be very 
effective at breaking up E. coli cell walls.  
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3.4.1 EVALUATING THE COMMERCIAL KITS 
 For the first experiment, blood spiked with known amounts of K12 genomic DNA 
were used to assess: 1) how well a kit will recover DNA assuming 100% cell lysis, and  
2) do contaminants in the final output inhibit the qPCR protocol established in Section 
3.2. The amount of blood lysed depended on the standard protocol provided by the 
manufacturer. Thus, 100 µl of blood was used for the QIAmp kit, while 50 µl were used 
for the rest. For each lysis protocol, blood was lysed with final concentrations (post lysis) 
of 0, 0.98, 9.8, 98, and 980 fg/µl K12 DNA. Each PCR reaction except for the no-K12 
controls should have at least 1 K12 genome, since 5 µl of post-lysis output was added to a 
PCR mixture and 1 E. coli genome is 4.7 fg. The ΔRn plots were analyzed by looking at: 
1) the CT of 0 fg/µl in blood, 2) the CT of 980 fg/µl K12 in blood, and 3) how well each 
 
Figure 13. Performance of QIAmp Blood Mini Kit on pre-purified K12 E. coli genomic 
DNA. 
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dilution was spaced, specifically, were there ~ 3.3 CTs between each concentration. The 
QIAmp DNA blood mini kit performed the best and is shown in Figure 13. All samples 
with K12 were above the NTC of the PCR solution, however, it was difficult to 
differentiate samples with 9.8 and 0.98 fg/µl, suggesting that the LOD of the QIAmp 
DNA blood mini kit to be 9.8 fg/µl K12, or about 2 E. coli CFU/µl.  
 
3.4.2 OPTIMIZING THE BOOM D PROTOCOL 
 The Boom D protocol was originally optimized for extracting HIV DNA from 
tens of microliters of whole blood. Before analyzing its ability to lyse E. coli in blood 
capabilities, it needed to be optimized for larger volumes, 100s of µl, of blood. In 
addition, the ethanol precipitation protocol was also optimized for such samples. For the 
new protocol, 250 µl of blood was used since sepsis patients may have as low as  
1 CFU/ml,71 and increasing the size of the patient sample would potentially increase the 
LOD. All ethanol precipitation and Boom D conditions tested are listed in Appendix B 
and C respectively. Briefly, various concentrations of Boom D, types of alcohol, 
precipitation salts, glycogen concentrations, and washing solutions were tested on blood 
samples with and without K12 genomic DNA. The final protocol was to vortex 250 µl of 
blood with 583 µl Boom D, 53 µl of 5 M NaCl, and 2 µl of 20 mg/ml glycogen. 
Following a 20 min incubation at room temperature, 478 µl of 1-butanol was added and 
vortexed again. The DNA was pelleted by spinning down at max speed in a 
microcentrifuge for 15 min. The supernatant was replaced with 1 ml of 70% ethanol 
solution with 12.5% Boom D. The addition of Boom D help to remove proteins co-
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precipitated with the DNA pellet. The tube was centrifuged for 10 min, and the 
supernatant was replaced with 70% ethanol to remove salt precipitated with the DNA. 
The pellet was then dried at ambient conditions and resuspended in 49 µl TE. Finally,  
1 µl of 10 mg/ml RNase A (Thermo Fisher Scientific, Waltham, MA, USA) was added, 
and incubated for 30 min at 37 °C. This step removes RNA co-precipitated with DNA 
that could potentially interfere with the PCR primers. The resulting samples were then 
quantified using the qPCR protocol from Section 3.2.  
 The lysis efficiency of the optimized Boom D lysis protocol was determined with 
Top10  competent E. coli cells transformed with stock pGEM-T Easy vectors. As a result, 
all 16S replication sites on the genomic DNA are expected to replicate. The E. coli were 
grown in LB until in log-phase confirmed by OD600. Serial dilutions of E. coli were 
generated down to 1 CFU/µl. Samples with 50 µl of 0, 102, and 103 CFU/µl were created. 
To confirm E. coli concentrations, 100 µl of the 1 CFU/µl stock were plated, incubated at 
37 °C overnight, and the colonies were counted. The samples were then spun down for  
15 min to pellet the bacterium. The LB was replaced with 250 µl blood. The optimized 
Boom D lysis protocol just described was used, and the E. coli was quantified using 
qPCR. The average number of E. coli on the plates was 572 bacteria. Thus, samples with 
102 and 103 CFU/µl E. coli actually had 5.72·102 and 5.72·103 CFU/µl E. coli. The results 
were promising as > 85% of E. coli was recovered, as shown in Figure 14, and the LOD 
was 123 CFU/ 5 µl, or 2,460 CFU/ml, based on the blood only samples. 
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Figure 14. Performance of Boom D protocol on lysing E. coli and purifying DNA. Error 
bars are one standard deviation from the mean. (n = 3) 
 
3.5 DISCUSSION 	
 The recovery results using the Boom D protocol greatly improved through this 
chapter. The initial results in Section 3.2.2 were poor with low recoveries and large error 
bars. After redesigning the PCR primers and probes, making purified standards, and 
optimizing the ethanol precipitation of DNA, PCR, and optimizing the Boom D protocol 
the recoveries improved and the error bars shrunk. However, the LOD of 2,460 CFU/ml 
is three orders of magnitude higher than the desired LOD of 1 CFU/ml.  
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 One easy solution to this problem is to increase the input volume. The current 
protocol started with 100 µl sample and it is physically impossible to consistently have an 
LOD of 1 CFU/ml as this translates to 0.1 CFU per sample. The input sample could be 
increased to 1 ml, but detecting 1 CFU would still be a stochastic function due to its 
rarity. This lead to the idea of designing a custom silica SPE column to process large 
volume samples. However, low amounts of DNA exist in both cases of large and small 
volume samples for sepsis application due low clinical concentrations. Assuming the 
lysis protocol was scalable, the aim of the thesis turned to exploring DNA-silica 
interactions for DNA-limited samples. 
 The DNA-limiting case of DNA-silica interactions is generally avoided by adding 
exogenous carrier DNA to increase the input. However, this is not ideal for POC devices 
that aim for simplicity, and the thesis will explore this space. The focus of the thesis 
aimed to optimize adsorption conditions to maximize DNA recovery using solutions 
favorable for qPCR, eliminating the need to ethanol precipitate DNA. At the same time, 
experiments were also structured to gain fundamental understanding of DNA-silica 
interactions to probe the mechanism to engineer better protocols to recover minute 
amounts of DNA from the silica surface. To get to that step, a protocol must first be 
designed and characterized to assess the DNA-silica interactions when a) DNA is 
adsorbed with the adsorption buffer, and b) DNA is recovered with an elution buffer. The 
former gives insight into how the interactions are formed to produce such strong 
adsorption, while the latter gives us knowledge how to break them and hopefully how to 
manipulate them to our advantage.  
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CHAPTER 4 
DESIGN OF A MINIATURED SILICA SOLID PHASE EXTRACTION DEVICE 
 
4.1 MICROFLUIDIC SEPARATION DESIGNS 
 
 Ideally, POC devices are handheld devices that process and analyze samples with 
minimal user input. Diagnostic devices that include a silica SPE column for DNA sample 
preparation have the following workflow as shown in Figure 15: 1) lyse patient sample, 
2) separate DNAs from solution via a silica SPE column, 3) elute purified DNA,  
4) amplify targeted DNA locus, and 5) quantify NAs.82 This thesis will focus on the 
separation and elution components of such a device. 
 
Figure 15. General protocol of DNA purification using silica SPE columns. A patient 
sample is initially collected and lysed to release all DNA from cells, bacteria, fungi, 
viruses, etc. The high salt content of the lysis buffer also promotes DNA adsorption onto 
the silica surface. The resulting solution then flows through the silica column to separate 
the DNA from other biomolecules in the solution. Following washing steps, the DNA is 
eluted off the silica using a low salt, high pH buffer. The target DNA in the purified 
sample is then amplified and detected. 
The aim is to design and build a test device to hold silica particles such that fluid 
can be flowed through them. Instead of having an immobile column as in Figure 15, our 
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solid phase will be free floating, and in particle form. Thus, it is crucial for the device to 
separate the silica particles from solution. Keeping the general workflow in mind, a 
protocol can be generated where 1) adsorption solution with DNA can flow though the 
silica allowing for DNA to adsorb, 2) particle can be washed with a washing buffer, and 
3) DNA can be recovered with an elution buffer. This replicated the separation and 
elution parts of Figure 15. In order to probe the DNA-silica interaction, we need the 
ability to collect solutions the adsorption buffer and elution buffer after it comes into 
contact with the silica particles to quantify 1) the unadsorbed DNA and 2) the recovered 
DNA. 
In this chapter, two test devices, with the above requirements, will be designed 
and compared. The first will attempt to also emulate typical microfluidic flow via 
positive air pressure by designing a porous polymer monolith (PPM) frit to hold the silica 
in place while solutions are flowed through. The second will use a macroscale 
polyvinylidene fluoride (PVDF) frit to separate out the silica from solution. This device 
will not emulate microfluidic flow, but it will allow for some steady state data that will 
give us better insight into DNA-silica adsorption. Finally, the two designs will be 
compared to evaluate which filtering method retains the least amount of DNA and 
thereby will be an inert bystander in future experiments. But first we’ll look at the 
characteristics of the silica particles that will be used throughout the remainder of the 
study. 
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4.1.1 SILICA 
 Davisil 643 silica particles (Sigma-Aldrich, St. Louis, MO, USA) were used for 
all subsequent experiments in this thesis. The particles are 35–70 µm in size with a 
surface area of 300 m2/g according to the manufacturer. The amorphous particle shape 
can be seen in the SEM images of the silica particles shown in Figure 16 were taken with 
a Zeiss (Oberkochen, Germany) Supra 55VP field emission SEM.  
During the following experiments, 50 mg of silica were mixed in 220 µl of 
ethanol by inversion, and 10 µl of the resulting suspension was added to 1.7 ml tubes. 
The ethanol was evaporated, and 2.2 ± 0.2 mg (n = 18) of silica remained with a 
 
Figure 16. SEM image of Davisil 643 silica particles mounted on copper tape. 
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calculated surface area of 0.66 ± 0.06 m2. Silica was also loaded in 0.5 mm diameter 
glass capillaries with polymerized frit-tips to hold the particles as in Section 4.1.2. The 
height of the silica column was measured to calculate the column volume (CV) of  
3.6 ± 0.3 µl (n = 24) knowing the inner diameter of the capillaries.  
 
4.1.2 SEPARATION VIA PPM FRITS 
 The first design was to use a PPM frits in a 100 µl glass capillary. The PPM was 
meant to act as a frit to keep the silica in place. Silica was loaded on top of the PPM, and 
solutions were flowed through the capillary using positive pressure via a manifold system 
attached to external air pressure custom designed in the Klapperich lab. This instrument, 
the ‘Blackbird’, is shown in Figure 17. The Blackbird was previously built to provide 
positive air pressure to multiple samples in parallel,80 but requires 200 µl Finntip pipette 
tip (Thermo Fisher Scientific, Waltham, MA, USA) to interface with. Pressure regulators 
for each capillary are separately controlled. Capillaries with bonded PPM filters were 
flame-bonded (melted) onto the pipette tips.  
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Figure 17. The multiplexed positive-pressure device called ‘the Blackbird.’ This device 
can provide positive pressure to up to 24 samples fitted with 200 µl Finntip pipette tips. 
Pressurized air enters the device through the yellow tubing and is split into four groups of 
six outlets where the pressure of each group can be adjusted individually. Additionally, 
every outlet has its own on/off switch for added control. The final image shows the 
Blackbird loaded with PPM-loaded capillaries attached to Finntip pipette tips. 
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This design allowed for the simulation of fluid flow similar to microfluidic 
devices as displayed in Figure 18. First, DNA in adsorption buffer was pushed through to 
adsorb the DNA onto the silica particles, and the solution could be collected afterwards to 
quantify the unadsorbed DNA. The particles were then washed with 70% ethanol, and 
finally the DNA was eluted with an elution buffer to quantify the DNA recovery. The 
PPM played a crucial role throughout this process to keep the silica particles in the 
capillary. 
 
Figure 18. Protocol for silica separation via PPM frit. Silica was loaded into the 
capillary, on top of the PPM. Adsorption buffer with DNA was pushed through with 
positive pressure to adsorb the DNA on the silica surface. Ethanol solution followed to 
wash the particles, and DNA was recovered using an elution buffer. 
The PPM frit was polymerized inside the capillary using free radical 
polymerization. Thermal initiators provided the free radicals to begin polymerization. 
Benzoyl peroxide (BPO)83 and potassium persulfate (KPS)84 were used since they are 
stable at room temperature, but their oxygen-oxygen bond decomposes at 60 °C resulting 
into two free radicals as shown in Table 3. A free radical can react with an alkene to form 
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a covalent bond, and in turn generated another free radical.85 This process propagates till 
all free radicals are consumed. This polymerization technique was also used to covalently 
bond the PPM to the capillary. The glass capillaries were silanized with  
3-(trimethoxysilyl)propyl methacrylate (TMSPMA),86 and its alkenes were able to react 
with the polymer solution. In this manner, the PPM stays in place, and can act as a frit to 
hold in the silica particles. The silanization protocol is in Appendix D. 
 The polymer solution to make a PPMs required four components: 1) monomer,  
2) crosslinker, 3) porogen, and 4) initiator.87 The monomers generate the backbone of the 
polymer, while the crosslinkers form links between chains. Adding more crosslinker 
increases the final rigidity of the polymer.88 The porogen is required to create pores. This 
component does not react nor polymerize, and is washed away post polymerization.89 
Finding a balance between the monomer/crosslinker to porogen ratio is vital to ensure the 
polymer network spanned the capillary cross section but was porous enough for liquid to 
flow through. 
 Both bulk and high internal phase emulsion (HIPE) polymerization methods were 
tried. Bulk polymerization entailed polymer solutions containing 40–50% porogen.90 The 
PPM polymerized from a homogeneous solution. As the monomers and crosslinkers 
began to aggregate throughout the mixture, they expelled the porogen from those 
regions.91 This created porogen-rich and polymer-rich regions that resulted in a single 
solid PPM filled with porogen-filed pores in an open pore structure.  
In contrast, the HIPE polymerization solution consisted of 75–92% porogen92 
achieved by creating a water-in-oil emulsion. The monomers and crosslinkers made up 
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the organic phase, while the porogen was the aqueous phase.93 The initiator can either be 
dissolved in the organic or the aqueous phase depending on its hydrophobicity. In 
addition, a surfactant was required to stabilize the phases so the water droplets didn’t 
coalesce.94 
 
Table 3. PPM components that were examined.  
 Different combinations of polymer components were tried. The monomers, 
crosslinkers, porogens, and initiators that were tested are in Table 3, and specific 
formulas are in Appendix E. The final polymer used for silica separation consisted of 
	56 
(glycidyl methacrylate) GMA and (divinylbenzene) DVB. Bulk polymerization was 
utilized by mixing 200 µl of inhibitor-free GMA and 200 µl of inhibitor-free DVB with  
8 mg BPO. After the BPO was fully dissolved, 400 µl 1-decanol and 200 µl 1-butanol 
were added, and vortexed until the solution was homogeneous. In TMSPMA-treated 
Kimble disposable 100 µl micro-capillaries (Thermo Fisher Scientific, Waltham, MA, 
USA), 5 µl of the GMA/DVB polymer solution was added. The capillaries were capped 
with hot glue to prevent ambient air molecules from consuming the free radicals. The 
polymer solutions were then incubated at 60 °C overnight to initiate the free radicals, and 
polymerize the solution. Following polymerization, the capillaries were scored with 
fragments of silicon wafers, and cut at the edge of the PPM and 2 cm away from the other 
side, as shown in Figure 19. To mount the capillaries on the Blackbird, 200 µl pipette tips 
were cut so the inner diameter of the tip was the same as the outer diameter of the 
capillary. The empty side of the capillary was then heated using a Bunsen burner just 
until it glowed red. It was immediately inserted into the narrow end of the pipette tip such 
that the PE in contact with the capillary melted and re-solidified around the glass. The 
new physical contact between the pipette tip and the capillary is able to withstand the 
positive air pressure from the Blackbird. The PPMs could then washed by flowing 
ethanol and methanol through the PPM at 40 PSI. Finally, the silica was loaded using the 
same protocol in Section 4.1.1. 
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Figure 19. Protocol to make PPM-bonded capillary for the Blackbird. The PPM solution 
was inserted into the capillary and the ends were sealed with hot glue to prevent air from 
reacting with the free radicals required for polymerization. The solution was incubated at 
60 °C overnight, and then cut to appropriate length. The Finntip pipette tips were cut such 
that the inner diameter matched the outer diameter of the capillary. This allowed the 
capillary to be heated and inserted into the pipette tip. The tip melted and re-solidified 
around the capillary forming a physical bond. 
 
4.1.3 SEPARATION VIA PVDF FRIT 
 The second design was to use Millipore Ultrafree-MC PVDF centrifugal filters 
(Thermo Fisher Scientific, Waltham, MA, USA) with 0.22 µm pore size to separate silica 
from solution. Liquid could be added to the frit and spun down in a centrifuge. This 
design did not simulate microfluidic flow as well as the PPM design, but PVDF isn’t 
known for adsorbing DNA, and the protocol could be modified to maximize adsorption 
and elution eliminating the factor of flow rate.  
 The general protocol is shown in Figure 20. Silica was initially incubated with 
DNA in an adsorption buffer at ambient temperature for 1 hr, while being rotated end-
over-end. This ensured equilibrium binding was reached. The mixture was then added to 
the PVDF frit and spun down in a microcentrifuge at max speed for 2 min. The filtrate 
was collected to quantify unadsorbed DNA. Afterwards, 70% ethanol was added and 
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spun down to wash the silica to remove excess salts leftover from the adsorption buffer. 
Then 100% ethanol was added, and spun down twice. This quickly dried the silica due to 
the extra spin and ethanol’s higher volatility compared to water. Once dried, the elution 
buffer was added, incubated with the particles for 5 min, before spinning it down, and 
collecting the filtrate to quantify amount of eluted DNA. The volume of elution buffer 
added to the silica particles was much greater than the column volume of the particles to 
maximize eluted DNA to ensure peak recovery occurred in the initial elution volume. 
 
Figure 20. Protocol for silica separation using PVDF frits. Silica, adsorption buffer, and 
DNA were mixed into a 1.7 ml centrifuge tube. The sample was incubated for 1 hr at 
ambient conditions while being spun end-over-end. The mixture was then placed on a 
PVDF filter, and spun down. The filtrate could be analyzed to quantify amount of DNA 
not adsorbed to the silica. The particles were then washed with 70% ethanol, followed by 
100% ethanol. Once the particles dried, elution buffer was added, incubated for 5 min at 
ambient conditions, then spun down and collected to quantify DNA recovery. 
 A bulk depletion experiment was conducted to confirm DNA adsorption 
equilibrated within an hour. Using the protocol just described, 1 µg λ-DNA (NEB, 
Ipswich, MA, USA) was incubated with 10 mg Davisil 643 silica in 500 µl 5 M GuSCN 
with 225 mM Tris-Cl (pH 8) for varying amounts of time. The post adsorption filtrates 
were collected and ethanol precipitated by the protocol in Section 3.3.3 to quantify 
unadsorbed DNA remaining in solution. The adsorption condition of 5 M GuSCN at pH 8 
was chosen since adsorption is expected to be weakest at that pH, and any transient 
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component to adsorption should be the slowest. The time points tested were 0, 0.5, 1, 2.5, 
5, 10, 20, 30, 40, 50, and 60 min. Some erratic behavior was expected for the initial time 
points due to the dynamic nature of the adsorption interactions. However, these 
interactions were expected to reach equilibrium by the end. These expectations were 
matched by the data as shown in Figure 21. Unadsorbed DNA fluctuated up and down up 
until 30 min, and then remained steady at ~ 0.2% unadsorbed λ-DNA, suggesting  
~ 99.8% adsorbed λ-DAN on the silica. This result suggested that equilibrium was 
reached sometime between 30–40 min. 
 
Figure 21. Percent of unadsorbed DNA for different incubation times in 5 M GuSCN 
(pH 8). DNA and silica were incubated for various time lengths and the data suggests 
equilibrium as reached at ~ 0.2% unadsorbed λ-DNA. Error bars are one standard 
deviation from the mean. (n = 3) 
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 An additional overnight incubation experiment was also conducted to verify 
equilibrium. Using the same adsorption solution (5 M GuSCN, pH 8) as previously, 3 mg 
of silica were incubated with varying amounts of λ-DNA ranging 5 pg – 5 µg. One set of 
samples were incubated for 1 hr at ambient temperature, while the other incubated 
overnight and then the silica was separated from solution. Again, filtrates were ethanol 
precipitated to quantify percent of unadsorbed DNA. As shown in Figure 22, the two sets 
of samples closely resembled each other suggesting equilibrium was reached within 1 hr, 
in agreement with the previous results. 
 
Figure 22. Percent of unadsorbed DNA for 1 hr and overnight incubations in 5 M 
GuSCN (pH 8). The DNA amounts examined ranged 5 pg – 5 µg. Both incubation times 
resulted in the same percent of unadsorbed DNA for 5 µg. Error bars are one standard 
deviation from the mean. (n = 3) 
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4.2 COMPARISON AND FINAL DESIGN 
 
 The two designs were compared to determine the better of the two. The PPM 
design simulated microfluidic flow better, but the PVDF frit ensured equilibrium 
adsorption, which removed experimental error from variations in flow rate. In 
experiments that will assess DNA-silica interactions, the frits should ideally adsorb only 
to the silica surface and not the frit. However, we must characterize the frits and 
compared the DNA retention ability of the PVDF and PPM frits. The frit that will retain 
the least amount of DNA will be used in experiments to assess DNA-silica interactions. 
Thus, experiments were conducted in the absence of silica to ascertain DNA retention.  
 Initial experiments using the PVDF frit design showed some background loss to 
the device itself. Solution containing 5 M GuSCN with 225 mM HCOONa (pH 3) was 
used with 160 pg, 16 ng, or 1.6 µg of λ –DNA were filtered through the PVDF frit. DNA 
was then ethanol precipitated, and resuspended in TE (pH 8). As shown in Figure 23, 
losses ranged between 9–30%. Losses were also observed using the PPM filter set up. 
Solution containing 5 M GuSCN with 225 mM HCOONa (pH 3) and 800 fg, 800 pg, or 
800 ng of λ –DNA was flowed through the PPM frit in the absence of silica. The results 
are shown in Figure 24 and the loss ranged from 46–63%. These two experiments 
weren’t directly comparable, but it confirmed both designs had inherent DNA retention 
characteristics, and an experiment was needed to directly compare the two.  
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Figure 23. DNA recovered from 5 M GuSCN (pH 3) spun through the PVDF frit in the 
absence of silica. Error bars are one standard deviation from the mean. (n = 2) 
 
Figure 24. DNA recovered from 5 M GuSCN (pH 3) pushed through PPM frit with 
positive pressure in the absence of silica. Error bars are one standard deviation from the 
mean. (n = 2) 
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 A thorough experiment was designed to compare the PPM frit to the PVDF frit. 
The adsorption buffers were chosen such that they would span the range of pH values of 
interest (pH 3–8), and assess DNA retention in the presence and absence of chaotropic 
ions. The solutions that were tested were buffered with 225 mM HCOONa (pH 3) or  
225 mM Tris-Cl (pH 8), with 0 M and 5 M GuSCN, and contained either 1 µg or 1 ng  
λ-DNA. Once the solutions were filtered, they were ethanol precipitated and quantified 
via qPCR.  
The results are plotted in Figure 25. The data suggests that under similar 
conditions, the PVDF frit device performed better and allowed for higher recoveries. 
 
Figure 25. Comparison of PVDF and PPM frits for different solutions. Solutions with 
DNA were run through the two filters with either 1 µg or 1 ng λ-DNA in the absence of 
silica. One hundred percent recovery indicates no DNA retention on the filter. Error bars 
are one standard deviation from the mean. (n = 2) 
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Thus, the PVDF frit test retained the less DNA than the PPM frit, and was used the 
following experiments in this study. 
 
4.2.2 ANALYSIS OF PROTEIN ADSORPTION 
 As an aside from DNA-silica only interactions, we looked briefly at protein 
interference for the application of silica SPEs with crude, clinical samples. It has been 
hypothesized that protein interference could reduce the effectiveness of the DNA-silica 
interactions. We ran experiments to establish the efficacy of a simple silica-based POC 
diagnostic device in the presence of protein contaminants. Specifically, we asked if the 
adsorption buffer require other chemical components to aid in the removal of proteins, 
which in turn would effect DNA adsorption. If such components were required, then 
adsorption and elution conditions would need to be optimized to contain them. 
 The PVDF frit design from Section 4.1.3 was used, and loaded with 20 mg of 
Davisil 643 silica particles. The silica was initially blocked with 500 µl of 1 mg/ml BSA. 
Subsequent centrifugation, 250 pg of E. coli genomic DNA in 500 µl of 5 M GuSCN 
with 225 mM MOPS (pH 7). Silica samples not blocked with BSA were also used as a 
control. In addition, adsorption solutions without GuSCN and/or MOPS were also used as 
controls. The filtrate from the adsorption solution was collected to quantify initial 
unadsorbed DNA. The particles were washed with 70% ethanol, dried, and eluted with 
500 µl TE (pH 8), which was collected post centrifugation. All filtrates were ethanol 
precipitated to improve DNA detection in the qPCR reaction. 
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 The results are shown in Figure 26. In the absence of GuSCN and MOPS, 93.6% 
of DNA remains unadsorbed, and this figure drops to 4.5% with MOPS, and to 0.1% with 
MOPS and GuSCN. This suggests the addition of MOPS and GuSCN are enough to 
overcome protein interference to DNA adsorption, and may be explained by the 
following two potential mechanisms: 1) The BSA remained on the silica, and the ions in 
solutions acted as a bridge between the protein and DNA or 2) the blocked protein 
desorbed from the silica surface, opening up locations where DNA could adsorb directly 
onto the silica. Chaotropes, such as GuSCN, are known to solubilize proteins, thus 
 
Figure 26. BSA blocking of silica. Bulk depletion experiments were conducted with 
different solutions containing 250 pg DNA. Silica samples with and without BSA 
blocking were used. The PVDF frit was used to separate the silica from the solutions and 
the DNA not adsorbed to the silica is displayed. Error bars are one standard deviation 
from the mean. (n = 2) 
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making the second explanation more plausible.51 Furthermore, the results of similar 
amounts of unadsorbed DNA for blocked and unblocked samples, for solutions other than 
water. Since DNA adsorbed directly to the silica surface for unblocked samples, then 
similar unadsorbed amounts for blocked samples suggest that DNA is adsorbing onto the 
silica surface for both. As a result, no additional chemicals were required to help remove 
proteins or aid in DNA purification. 
 
4.3 DISCUSSION 
 
 The PVDF frit design retained less DNA than the PPM frit. The data was unclear 
whether DNA lost in the PPM protocol adsorbed on the PPM or the capillary wall, but 
the inherent retention to the device was larger.  
 Microfluidic flow was not mimicked during the adsorption step with the PVDF 
frit, but this design allowed for the analysis of adsorption without the variable of flow 
rate, since the conditions for equilibrium in this design were easy to achieve and control. 
The equilibrium experiments in Section 4.1.3 demonstrated that equilibrium during the 
initial incubation was reached by 40 min. Reaching equilibrium then eliminates the 
inevitable question when analyzing DNA recoveries during elution: how much of the 
observed recovery was effected by DNA that did not adsorbed due to transient factors? 
We expect the aqueous conditions of adsorption to influence the final equilibrium DNA 
concentration on the surface, but this design has eliminated the transient component of 
these interactions allowing the interpretations of future data to focus on the chemistry 
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principles of DNA adsorption. These two factors together led us to choose the PVDF frit 
design as the platform for subsequent explorations of the bind and release process of 
DNA on silica. 
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CHAPTER 5 
QUANTIFYING DNA-SILICA INTERACTIONS 	
 
As discussed in the background, DNA-silica interactions are influenced by pH, 
ionic strength, silica surface groups, DNA amount, chaotrope presence, and total silica 
surface area. Although some of these variables are interrelated, exploring all of them 
would have been ambitious. This thesis focused on the variables in the aqueous solution. 
Silica surface groups and total silica surface area were controlled by using the same 
source and amount of silica for a given experiment. This limited the exploration of the 
geminal to single silanol ratio (Q2:Q3), and surface group concentration variability 
between silica fabrication methods. Further, the pH range was limited to pH 3–8 due to 
the depurination of DNA at pH 2 and the dissolution of silica at pH 8–10. 
The following experiments cover pH, chaotrope, and DNA concentration effects 
on DNA-silica interactions. Using the PVDF frit from Section 4.1.3, these variables were 
examined during the adsorption step of the protocol. Post washing, DNA was eluted with 
standard low salt, high pH buffers, such as TE and Buffer EB. The elution buffer 
conditions were further evaluated by using different solutions. Additionally, DNA 
amounts used were < 5 µg DNA to be relevant for low-copy samples, relevant to POC 
diagnostic applications, and outside commercial device applications. 
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5.1 GENERAL PROTOCOL 
 
 In the following experiments, we quantified the unadsorbed and recovered DNA 
to account for all of the DNA throughout the protocol. The general experimental flow is 
shown in Figure 27, and experiments in this chapter are variations of this protocol. The 
initial steps are from the PVDF frit design in Section 4.1.3. Silica particles, DNA, and the 
adsorption buffer were mixed in a 1.7 ml centrifuge tube, and incubated for 1 hr at 
ambient conditions while being rotated end-over-end. This step allowed the DNA-silica 
binding to equilibrate. A PVDF frit was subsequently used to separate the silica particles 
 
Figure 27. General protocol for experiments in Chapter 5. DNA-silica interactions were 
examined using the PVDF frit protocol designed in Section 4.1.3. Silica particles, DNA, 
and an adsorption buffer were mixed and incubated. The silica particles were separated 
using a PVDF frit and the filtrate was collected. The particles were subsequently washed, 
and DNA was recovered with an elution buffer. The DNA in the collected filtrates was 
then ethanol precipitated by adding NaCl, glycogen, and isopropanol. The mixtures were 
centrifuged for the DNA to form pellets. The pellets were washed with 70% ethanol, 
before being resuspended in a low salt, high pH buffer. The resulting purified DNA 
samples were then quantified via qPCR. 
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from solution via centrifugation. The filtrate was collected to quantify the initial amount 
of unadsorbed DNA that will be refereed to as ‘Lost DNA,’ since it would be 
unrecoverable in the context of POC diagnostic devices. The silica particles were then 
washed with 70% ethanol, followed by 100% ethanol, and dried. An elution buffer was 
added to the silica particles, incubated for 5 min, and spun down to collect the filtrate. 
This solution contained DNA eluted from the silica surface, and will be referred to as 
‘Recovered DNA’, since this DNA would be retrieved, and continued down the workflow 
of a POC diagnostic device. In some experiments, additional elutions were collected.  
 The DNA in the ‘Lost DNA’ and ‘Recovered DNA’ filtrates were ethanol 
precipitated post collection similar to the protocol in Section 3.2.1. This step was required 
to remove salts that would interfere with the qPCR reaction that was used to quantify 
DNA. In general, 5 µl of 20 mg/ml of glycogen, NaCl to final concentration of 0.3 M, 
and Buffer EB was added to samples to neutralize the charges on the DNA backbone. 
After vortexing the solutions, the volumes were doubled with isopropanol, and vortexed 
again. The addition of Buffer EB in the previous step minimized salt precipitation after 
the isopropanol was added. The resulting solutions were centrifuged at max speed for  
15 min at 22 °C to pellet the precipitated DNA in the bottom of the tube. The 
supernatants were replaced with 70% ethanol, spun down at max speed for 10 min, and 
washed once more with fresh 70% ethanol. The pellets were dried for 15 min at ambient 
conditions, and resuspended in low salt, a high pH buffer, Buffer EB. This buffer was 
chosen since it does not interfere with the PCR reaction that was used for quantification. 
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 The purified DNA samples were quantified using the PCR protocols developed in 
Section 3.3.1. The PCR primers and probes used depended on the DNA used in each 
experiment: E. coli genomic DNA, rrsB-pGEM-T Easy vectors, or λ-DNA. However, the 
PCR reaction mix and the temperature profile used were the same. The PCR reaction 
mixture consisted of 9.5 µl water, 5 µl sample, 2.5 µl Core SureStart buffer, 1.5 µl of  
50 mM MgCl2, 1.5 µl of 4 µM forward primer, 1.5 µl of 4 µM reverse primer, 1 µl of  
20 mM dNTP, 1 µl of 100 mM DTT, 0.75 µl of 1:999 dilute 1 mM Rox reference dye, 
0.5 µl of 10 µM Taqman probe, and 0.25 µl SureStart Taq DNA polymerase. The 
temperature profile used was 15 min at 95 °C, followed by 40 cycles of 30 sec at 95 °C 
for denaturing, 5 sec at 65 °C for annealing and 30 sec at 72 °C for extending. PCR 
reactions were run on a 96-well plate and each sample was run in duplicates. Each plate 
also included a set of known standards that covered the range of potential DNA amounts 
in the experimentally generated samples. 
 This general protocol was used as a basis to conduct various experiments and 
change different variables that effected DNA-silica interactions. We examined the effects 
of amount of DNA, amount of silica particles, adsorption conditions, and elution buffers 
on DNA adsorption and recoverability. A brief description of each experimental protocol 
in this chapter is included in the following sections, and detailed protocols are available 
in Appendix D. 
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5.2 pH AND CHAOTROPE EFFECTS 
 
5.2.1 DNA LOSS AND RECOVERY WITH 2.5 µg INPUT DNA 
 The goal of this experiment was to establish a baseline for DNA-silica 
interactions at the limit of the previously studied regimes of ~ 1 µg. As mentioned 
previously, the manufacturing method of silica influences the surface silanol 
concentrations of Q3 and Q2. Unlike previous work in the literature, we performed all of 
the following experiments using the same silica surface material, so that results of 
upcoming experiments could be directly compared.  
 
METHODS 
This study evaluated the effects of pH and chaotropic agents on 2.5 µg of E. coli 
genomic DNA and 20 mg Davisil 643 silica particles. Adsorption buffers contained 5 M 
GuHCl, 5 M GuSCN, or 5 M NaSCN and were buffered with either 225 mM HCOONa 
(pH 3) or 225 mM Tris-Cl (pH 8). These conditions were chosen since pH 3 and 8 span 
the range of potential pH values taking into account the depurination of DNA (pH 2) and 
the dissolution of silica (pH 8–10). The chaotropic salts were chosen to isolate potential 
effects between cationic and ionic chaotropic agents, since Gu and SCN are chaotropic 
while Na and Cl are kosmotropic. The protocol in Section 5.1 was used to quantify lost 
DNA from the different adsorption buffers and recovered DNA was eluted with Buffer 
EB. Following the Buffer EB elution, a second elution with 95 °C formamide was 
collected. This second elution was chosen since both 95 °C and formamide are known to 
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disrupt hydrogen bonding,7 and could give insight into DNA-silica interactions, 
specifically if the previous hypothesis that the interactions include hydrogen bonding is 
true.11 As a result, every sample where DNA was incubated with silica three filtrates were 
collected: 1) lost DNA quantifying the initial unadsorbed DNA, 2) recovered DNA using 
Buffer EB, and 3) recovered DNA with 95 °C formamide. A more detailed description of 
these methods is in Appendix D. 
 
RESULTS 
Lost DNA minimized at low pH 
 Adsorption was analyzed by comparing the percent of lost DNA after incubating 
2.5 µg E. coli genomic DNA with 20 mg silica particles in different adsorption buffers. In 
all cases, > 99% of DNA remained adsorbed on the silica surface, but there were 
differences in how little DNA remained in solution post incubation. The results suggested 
pH was the predominant effect as displayed in Figure 28. Undetectable amounts of DNA 
were lost when adsorbed with 5 M NaSCN at pH 3, since the amount quantified was 
below the LOD. The lost DNA jumped up to 0.0007% with the other chaotropes at pH 3. 
Losses were increased two order of magnitude to 0.01–0.52% when adsorbed at pH 8. 
Additionally, differences between chaotropes were inconclusive as the pH 3 data points 
were overlapping, and the error bars for the pH 8 data were large. 
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Figure 28. Lost DNA after incubating 2.5 µg E. coli genomic DNA with 20 mg silica 
particles given in various adsorption buffers. The plot shows percent of DNA not 
adsorbed after the initial 1 hr incubation in a variety of adsorption buffers. The NaSCN 
data at pH 3 is not displayed because the DNA amount quantified was below the LOD. 
Error bars are one standard deviation from the mean. (n = 3) 
Majority of DNA remains adsorbed on silica post EB elution 
There was little difference in the elution data as Figure 29 shows. Recovered 
DNA with Buffer EB ranged 16–31% independent of pH and chaotropic agent. As a 
result 69–84% of DNA was unrecoverable by the golden standard method of eluting with 
a low salt, high pH buffer. With 2.5 µg DNA, it was expected that DNA recovery with 
Buffer EB would be higher from previous literature. However, the experimental 
conditions lead to a DNA-limiting situation. As will be further explained in Section 5.5, 
the DNA per surface area was much lower than previously reported adsorption capacities 
	75 
of silica surface of 240–800 µg DNA/m2 silica surface. The maximum surface density of 
DNA in this experiment was 422 ng DNA/m2 silica from 2.5 µg DNA on 20 mg Davisil 
643 silica. 
 
Figure 29. Recovered DNA using Buffer EB post adsorption with different buffers. The 
plot shows the percent DNA recovered using Buffer EB after it was initially adsorbed 
with different adsorption buffers. Error bars are one standard deviation from the mean.  
(n = 3)  
Formamide elutions suggest hydrogen bonding plays role 
 The recovered DNA with 95 °C formamide was similar to the recoveries with 
Buffer EB as shown in Figure 30. For adsorption with 5 M GuSCN and GuHCl, 
recoveries appear independent of pH since values ranged 22–38% for pH 3 and 29–32% 
for pH 8. DNA recovery after being adsorbed with 5 M NaSCN doubled from 25% to 
51% from pH 3 to 8. This result suggests that a pH dependence may exist with 
formamide elutions when adsorbing with 5 M NaSCN, but it is difficult to decouple this 
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from effects induced by the Buffer EB elutions. In other words, would the recovered 
DNA amount using formamide be replicated if the silica weren’t first eluted with Buffer 
EB? Unfortunately this was unclear since about 30% of DNA was already recovered with 
Buffer EB before the formamide elution was collected. 
 
Figure 30. Recovered DNA using 95 °C formamide post Buffer EB elution for different 
adsorption buffers. The plot shows the percent DNA recovered using Buffer EB after it 
was initially adsorbed with different adsorption buffers. Error bars are one standard 
deviation from the mean. (n = 3) 
5.2.2 DNA LOSS AND RECOVERY WITH 2.5 pg INPUT DNA 
 This study was aimed to repeat the previous experiment with less DNA. Due to 
the large size of E. coli genomic DNA, rrsB-pGEM-T Easy vectors were used instead. 
Knowing that the pKa’s of silica are at pH 4.5 and 8.5, we also examined adsorption 
buffers at pH 5.2 along with pH 3 and 8. 
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METHODS 
The adsorption buffers contained 5 M GuHCl, 5 M GuSCN, or 5 M NaSCN and 
were buffered with 225 mM HCOONa (pH 3), 225 mM C2H3NaO2 (pH 5.2), or 225 mM 
Tris-Cl (pH 8) leading to nine total combinations. Again 20 mg Davisil 643 silica was 
used for each sample with 2.5 pg rrsB-pGEM-T Easy vectors. After incubating the DNA, 
silica, and adsorption buffers, three samples were collected per protocol in Section 5.2 
and Section 5.2.1: 1) lost DNA, 2) recovered DNA using Buffer EB, and 3) recovered 
DNA with 95 °C formamide. The samples collected were ethanol precipitated, and 
quantified using qPCR. A more detailed description of these methods is in Appendix D. 
 
RESULTS 
LOD too high to quantified results 
 It was difficult to discern trends from the adsorption data as displayed in Figure 
31. Similar to the results in Section 5.2.1, > 98% of DNA was adsorbed on the silica 
surface. In terms of lost DNA, DNA was undetectable for DNA adsorbed with 5 M 
NaSCN for all pH and with 5 M GuHCl for pH 3 and 5.2 as it was below the LOD. DNA 
lost when adsorbed with 5 M GuSCN, although detectable, did also not exhibit any 
discernable trends. The results do, however, suggest DNA-silica interactions are weakest 
when adsorbed with 5 M GuSCN since some DNA remained unadsorbed post incubation.  
The adsorption buffers that resulted in undetectable amounts of DNA were a 
result of the LOD of 50 rrsB-pGEM-T Easy vector copies from the qPCR protocol. To 
get to 2.5 pg of DNA, 5·105 copies were used that were purified in 50 µl Buffer EB once 
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ethanol precipitation was complete. The qPCR protocol had an LOD Of 5 copies/5 µl 
samples resulting in the overall LOD of 50 rrsB-pGEM-T Easy vector copies. Thus, it 
was impossible to quantify lost DNA below 0.01%. 
 
Figure 31. Lost DNA after incubating 2.5 pg rrsB-pGEM-T Easy vectors with 20 mg 
silica particles given in various adsorption buffers. The plot shows percent of DNA not 
adsorbed after the initial 1 hr incubation in a variety of adsorption buffers. The NaSCN 
data and GuHCl at pH 3 and 5.2 are not displayed because the DNA amounts quantified 
were below the LOD. Error bars are one standard deviation from the mean. (n = 3) 
Increased DNA recovery with Buffer EB at high pH 
 The recovered DNA with Buffer EB, as shown in Figure 32, suggests that it 
depends on pH irrespective of chaotropic agent. DNA recovery ranged 2–5% for DNA 
adsorbed at pH 3 and 5.2. It increased to 18–26% for pH 8. This suggests Buffer EB 
cannot overcome the DNA-silica interactions established during adsorption at pH 3 and 
5.2, but the interaction at pH 8 are slightly different, and elution was increased four-fold. 
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This is likely due to the increased electrostatic repulsion between DNA and silica in basic 
pH conditions. 
 
Figure 32. Recovered DNA using Buffer EB post adsorption with different buffers. The 
plot shows the percent DNA recovered using Buffer EB after it was initially adsorbed 
with different adsorption buffers. Error bars are one standard deviation from the mean.  
(n = 3) 
Formamide elutions suggest hydrogen bonding plays role 
 The recovered DNA with 95 °C formamide increased even after the initial elution 
with Buffer EB, as shown in Figure 33. DNA recovery for DNA adsorbed at pH 3 and 5.2 
more than doubled, while recovery for DNA adsorbed at pH 8 increased by > 10%. This 
increase in recovery suggests that hydrogen bonding plays a role in DNA-silica 
interactions since formamide can disrupt hydrogen bonding, unlike Buffer EB. 
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Figure 33. Recovered DNA using 95 °C formamide post Buffer EB elution for different 
adsorption buffers. The plot shows the percent DNA recovered using Buffer EB after it 
was initially adsorbed with different adsorption buffers. Error bars are one standard 
deviation from the mean. (n = 3) 
 
5.3 EFFECT OF DNA INPUT MATERIAL ON RECOVERY 
 
 The results in Section 5.2 suggest little difference between the three chaotropes in 
question. GuSCN was chosen to further explore DNA-silica interactions. Differences 
existed in the DNA recoveries between 2.5 µg DNA and 2.5 pg DNA. To understand this 
disparity, the entire range of 2.5 pg – 2.5 µg DNA was examined.  
 
5.3.1 METHODS 
The general protocol from Section 5.1 was used. For this set of experiments, 
adsorption buffers contained 0 M and 5 M GuSCN, and were buffered with 225 mM 
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HCOONa (pH 3), 225 mM C2H3NaO2 (pH 5.2), and 225 mM Tris-Cl (pH 8). In total, six 
different adsorption buffers were tested. Initially, silica was loaded in the 1.7 ml tube by 
dispensing 10 µl of 50 mg Davisil 643 silica particles suspended in 220 µl ethanol and 
allowed to dry. This left behind 2.2 ± 0.2 mg (n = 18) silica. Afterwards, 390 µl of the 
desired adsorption buffer was added with 10 µl containing 1 pg – 1 µg λ-DNA. The 
mixture was incubated for 1 hr, the silica particles were separated using the PVDF frit, 
and the filtrate was collected to quantify the lost DNA. The particles were subsequently 
washed, dried, and an elution with Buffer EB was collected to quantify the recovered 
DNA. The collected filtrate were ethanol precipitated before being quantified via qPCR. 
The λ-DNA primers and probe were used in the qPCR mixture. A more detailed 
description of these methods is in Appendix D. 
   
5.3.2 RESULTS 
Strongest DNA adsorption occurs at low pH with GuSCN 
To analyze the adsorption efficiency of DNA on silica, we explored the amount of 
lost DNA. We begin by examining the DNA loss mechanisms. In Figure 34, we observed 
that regardless of the presence or absence of GuSCN during the DNA adsorption process, 
the highest DNA loss occurred at pH 8. Since pH 8 is significantly above the first silanol 
pKa (4.5) and near the second pKa (8.5), the data supports the theory in which an overall 
negatively-charged silica surface is electrostatically repelling the negative-charged DNA 
phosphate backbone. Moreover, the data also support previous studies, in which silica 
dissolution at pH 8–10 inhibits DNA adsorption. In essence, the pH 8 data reinforces the 
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common observation that commercial NA extraction kits perform poorly at high pH.  
 
 
Figure 34. Lost DNA following incubation with silica. Plots show amount of DNA not 
adsorbed to silica after 1 hr of incubation for each adsorption buffer. Note that DNA loss 
for 2.5, 25, and 250 pg/mL are not shown for adsorption with 5 M GuSCN pH 3 buffer, 
since the signal from those values fell below the LOD. Error bars are one standard 
deviation from the mean. (n = 3) 
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Next, we observed an overall enhanced DNA adsorption at pH 3 and 5.2. The 
addition of GuSCN increases adsorption by an order of magnitude at these pH values. For 
input DNA less than 25 ng/mL, at pH 3, the amount of DNA loss during initial adsorption 
is less than 0.1%. At higher input DNA concentrations, the percent loss also increases, 
presumably due to increased surface coverage by additional DNA molecules. Similar 
results are seen at pH 5.2, albeit with the initial loss of 1.6–3.8%. This supports the 
theory that surface charges inhibit DNA-silica adsorption. Since isoelectric points of 
DNA and silica are 5 and 1.5–3.6 respectively, the decrease in the level of negative-
negative charge repulsions would presumably make DNA-silica interactions more 
favorable in an acidic environment. The data supports this expectation, since DNA loss 
was the lowest for pH 3, increased for pH 5.2, and reached a peak at pH 8, controlling for 
the presence of GuSCN. We acknowledge that the error bars for DNA adsorbed at pH 5.2 
without GuSCN appear larger than the other results in the plot; however, we believe this 
visual anomaly is mainly due to plotting the data in a log-log plot. The standard 
deviations ranged 0.7–10.4%, which are less than the pH 8 standard deviations that 
ranged 4.8–23.2% for the same input concentrations. Adsorption at pH 3 was stronger, 
and resulted in smaller standard deviations (0.01–1.7%), suggesting that adsorption at pH 
5.2 is of strength between that at pH 3 and pH 8. 
 
Optimal DNA recovery after adsorption with 5 M GuSCN at pH 5.2 
Here, we analyze the elution efficiency through the amount of DNA recovered for 
DNA initially adsorbed in different adsorption buffers. In Figure 35, all samples were 
	84 
eluted with Buffer EB (10 mM Tris-Cl, pH 8.5), which is the gold standard for DNA-
silica extraction columns. Across all DNA concentrations, the DNA recovery ranged 
between 0.8–11.54% for adsorption buffers without GuSCN. These results suggest that 
eliminating GuSCN during adsorption would render at least 71% of DNA to be deemed 
 
Figure 35. Recovered DNA using Buffer EB from silica. The plots show DNA recovered 
from the silica surface after DNA incubation with different adsorption buffer. All 
samples were eluted with Buffer EB (10 mM Tris-Cl pH 8.5). Error bars are one standard 
deviation from the mean. (n = 3) 
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unrecoverable during the entire extraction process. Such losses make these conditions 
unfavorable for clinical applications.  
On the other hand, the addition of GuSCN appears to improve the levels of DNA 
recovery for some adsorption conditions. When the input DNA concentrations were less 
than ≤ 2.5 ng/mL, DNA recovery from adsorption buffers with 5 M GuSCN exhibits 
similar behavior of adsorption buffers without GuSCN. In these cases, the recoveries 
ranged from 1.2–28.3%. For input concentrations > 2.5 ng/mL, the DNA recovery did not 
improve when DNA was adsorbed with 5 M GuSCN at pH 3 or 8. However, DNA 
recovery following adsorption with 5 M GuSCN (pH 5.2) increased to 40.3% and 53.5% 
for 250 ng/mL and 2.5 µg/mL input DNA respectively. Since results from Figure 34 
showed that the strongest adsorption occurred at pH 3, we suspect the weaker adsorption 
at pH 5.2 in Figure 34 facilitated the corresponding improvement in elution efficiency in 
Figure 35. 
 
5.4 ELUTION BUFFER EFFECTS 	
In our series of experiments, the largest percentage of DNA recovered in Section 
5.3 was 53.5%, which is far from ideal for clinical applications. In an effort to improve 
this yield, and further understand DNA-silica interactions, we studied the effectiveness of 
different elution buffers. In Section 5.3, we established that adsorption with 5 M GuSCN 
at pH 3 resulted in the least amount of lost DNA, thereby forming the strongest DNA-
silica interaction. In this section, we attempted to disrupt specific molecular interactions 
of this interaction by eluting with different buffers. Each buffer targeting a specific 
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interaction (electrostatic forces, hydrophobic forces, and hydrogen bonding) would 
recover a different amount of DNA, and should be equivalent to that interaction’s 
dominance between the DNA and silica. This allowed us to deconstructively interrogate 
the presence and dominance different molecular interactions including electrostatic 
forces, hydrogen bonding, and hydrophobic forces. Some samples were eluted with 1 M 
NaOH, which dissolved the silica surface, and disrupt all molecular interactions. This 
should maximize DNA recovery. Other adsorbed DNA were eluted with 95 °C 
formamide to disrupt only hydrogen bonding, and 0.5 M Tris-Cl (pH 8) was used to 
disrupt electrostatic interactions. Additionally, Buffer EB was used as the gold standard 
control, and water was used as an entropic control, since it doesn’t target any interactions 
and some DNA could potentially elute to maximize entropy due to the initial lack of 
DNA in elution buffer. 
In Melzak et al., the hypothesized theory of chaotrope-mediated DNA adsorption 
on silica states: At low pH, where adsorption is strongest, DNA is driven onto the surface 
through dehydration effects cause by the chaotrope, which enabled the formation of 
hydrogen bonds.11 This theory was based on how globular proteins adsorbed to 
polystyrene (PS).61 For this to be true, we hypothesized that 1 M NaOH would recover 
the most DNA by virtues of high-pH silica dissolution.95 Likewise, elutions with 95 °C 
formamide (hot formamide) would liberate DNA on the basis of hydrogen bond 
disruptions. If the combination of hot formamide and 1 M NaOH (pH 13) resulted in the 
largest DNA recovery, it would support the hyporthesis that hydrogen bonding and 
hydrophobic interactions dominate the DNA adsorption process. Finally, water, Buffer 
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EB, and 0.5 M Tris-Cl (pH 8) should play a minor role in these interactions and recover 
less DNA. 
 
5.4.1 METHODS 
One adsorption condition was tested in this experiment using a protocol similar to 
the one in Section 5.1. In 1.7 ml tubes, 5 M GuSCN (pH 3), 2.2 mg silica and 1 µg λ-
DNA were incubated for 1 hr. The silica was separated using the PVDF frit, washed 
dried, and four serial elutions of 400 µl were collected using the following solutions:  
1) water, 2) Buffer EB, 3) 0.5 M Tris-Cl (pH 8), 4) 95 °C formamide, and 5) 1 M NaOH. 
It is expected that DNA recovery will peak during first elution since 2.2 mg silica has a 
CV of 3.6 µl, and elution volume is 400 µl. Thus, void volume effects are not expected to 
be observable in the results, and recovered DNA should peak in the first elution. A more 
detailed description of these methods are in Appendix D. 
 
5.4.2 RESULTS 
The DNA-silica-chaotrope interaction at low pH is dominated by hydrophobic forces 
 The elution curve data is shown in Figure 36. As hypothesized, the 1 M NaOH 
and 95 °C formamide elutions resulted in the largest DNA recoveries with 71.9% and 
27.5% respectively in the initial elution volume. Recoveries dropped to < 3% following 
the first elution fraction. For all other elution buffers, the DNA recovery ranged between 
0.04–2.63%, suggesting that ionic interactions and entropic effects play a minor rols in 
DNA-silica interactions at low pH. Next, when analysis of variance (ANOVA) was used 
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to compare the elution buffer efficacy for the first elution fractions, we found at least one 
of the elution buffers exhibit a statistically-different DNA recovery percentage among the 
group of five buffers [F(4,10) = 2649, P < 10-17]. Furthermore, an a posteriori Tukey test 
showed that DNA recovery using 1 M NaOH and 95 °C formamide were significantly 
  
 
Figure 36. Elution of DNA from silica using varying elution buffers. Amount of 
recovered DNA using five different elution buffers. Samples were eluted after 1 µg DNA 
was adsorbed with silica in with 5 M GUSCN (pH 3). Error bars are one standard 
deviation from the mean. (n = 3) 
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different to recoveries using Buffer EB, water, and 50 mM Tris-Cl (pH 8.5) at  
α = 0.01. In addition, there was a significant difference in DNA recovery using 1 M 
NaOH versus 95 °C formamide at α = 0.01. 
 
5.5 DISCUSSION 
 
The DNA loss data suggests that DNA adsorption on silica is mainly dependent 
on pH. DNA has an inherently greater affinity for the silica surface in acidic 
environments. However, the addition of a chaotrope does increase the surface affinity for 
DNA at pH 3 and 5.2. We expected this result because the isoelectric points of DNA and 
silica are 5 and 1.5–3.6 respectively. At pH 3, we do not expect electrostatics to interfere 
with the chaotropic mechanism that increases DNA adsorption, resulting in the highest 
surface affinity. Both the DNA and the silica surface become more negative at pH 5.2, 
and the corresponding increase in electrostatic repulsion results in more DNA loss. At pH 
8, the loss is maximized alongside the electrostatic repulsion. The observed decreased 
lost DNA in the presence of a chaotrope can be attributed the chaotrope’s dehydrating 
ability.96 Thus, the dehydrated DNA has a higher affinity for the silica surface than the 
polar aqueous environment.11 Our DNA loss results are consistent with previous studies 
using higher concentrations of DNA.11,54 
Focusing on events downstream of the DNA adsorption process, our elution 
results suggest that an increase in DNA adsorption capacity at low pH does not 
necessarily leads to a higher DNA recovery rate. Instead, the best DNA recovery results 
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were obtained by taking advantage of a weaker DNA-silica-chaotrope adsorption 
complex facilitated at the intermediate pH of 5.2. We believe the gold standard is a low 
salt, high pH elution, was not able to disrupt the DNA-silica-chaotrope complex created 
at pH 3, where DNA recovery didn’t exceed 10.1%. Conversely, when the solid-phase 
complex was formed at pH 8, weak DNA adsorption events resulted in massive 48.8% 
DNA loss even prior to the EB elution steps. Thus, a DNA-silica-chaotrope adsorption 
event at pH 5.2 represents an optimum situation where: a) the initial DNA loss due to a 
weaker solid-phase complex is offset by b) an ease in complex dissociation with Buffer 
EB at pH 8.5, thus resulting in a multi-factor local maximum in total DNA recovery. 
Diving deeper into Figure 36, a maximum DNA recovery with 1 M NaOH 
suggests that hydrophobic forces dominate DNA-silica-chaotrope association events in a 
pH 3 environment. In arriving to this conclusion, we first employed buffers EB and 0.5 M 
Tris-Cl (pH 8.5) in an attempt to induce DNA repulsion, and remove DNA from the silica 
by deprotonating both the DNA phosphate groups and surface silanol groups. 
Unfortunately, > 98% of the captured DNA remained on the surface, and only 2% of the 
bound DNA was recovered. Next, a 95 °C formamide solution was used disrupted the 
hydrogen bonding between the DNA and silica surface, resulting in a higher recovery of 
27.5%. Finally, a series of 1 M NaOH elutions resulted in 71.9% DNA recovery. Since 
NaOH completely destroys the DNA-silica-chaotrope complex via silica dissolution, the 
high level of NaOH-dependent DNA liberation suggests that hydrophobic interactions 
play a larger role than hydrogen bonding or ionic interactions in the initial processes of 
adsorption complex formation at pH 3. We expected the lack of ionic interactions was 
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due to the fact that phosphate and silanol surface groups are protonated and charge-
neutralized at pH 3. Thus, if the destruction of all possible hydrogen bonds with hot 
formamide only amounted to liberating a small portion (27.5%) of the entire pool of 
adsorbed DNA molecules, then hydrophobic interactions are the likely dominant force 
that holds the DNA-silica-chaotrope complex together at low pH. 
The experiments were conducted such that DNA, rather than the available 
surface, was the limiting factor for adsorption. Existing literature has shown that the 
adsorption capacity for DNA is 240–800 µg DNA/m2 of silica in the presence of a 
chaotrope, depending on the pH of the adsorption solution.11,32,33 Our results support the 
model in which the adsorption capacity increases with decreasing pH. Due to 
experimental design constraints in Sections 5.2, 5.3 and 5.4, the maximum DNA 
adsorption that could be achieved was 1.52 µg DNA/m2 silica for 1 µg total DNA. In this 
regime, when using GuSCN, no appreciable DNA was adsorbed at pH 8 and no 
appreciable DNA will be eluted when adsorbed at pH 3. This is in contrast to other 
experimental designs in the literature that have demonstrated recovery of significant 
amounts of DNA after adsorbing at pH 5, 6.7, or 8, with the caveat that the amount of 
unrecoverable DNA within the system was not addressed.13,32,33 To elaborate, these 
studies were conducted using large concentrations of input DNA, such that the net 
unrecoverable amount of DNA is negligible compared to the net recovered.13,32,33 These 
differences become vital when one is trying to use silica columns to bind and release 
minute amounts of total DNA from NA-dilute clinical samples solutions. Of course, most 
commercial kits address this problem by adding exogenous DNA to artificially increase 
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the overall DNA load. However, this approach is not ideal in POC applications, since 
adding reagents increases cost, complexity, and volume to devices that need to be as 
inexpensive, simple, and small as possible.  
Our results suggest that the standard method for eluting DNA using Buffer EB 
from silica following chaotrope-mediated adsorption may not be ideal for low 
concentration of DNA. Only two conditions allowed for the recovery of more than 30% 
of input DNA with Buffer EB. Based on these results, DNA recovery depends on 1) the 
concentration of initial DNA input, 2) the adsorption pH, 3) the presence of a chaotrope, 
and 4) the elution buffer. It also depends on the ratio of input DNA to the available 
surface area of silica when comparing to previous results. Thus, designing a device to use 
this technology requires not only an understanding of the DNA-silica-chaotrope 
interaction, but also understanding the dynamic range of characteristics associated with 
clinical samples, and how sample preparation steps affect these characteristics. Our 
results also suggest that we can increase the range of initial sample conditions by utilizing 
harsher elution condition, although not ideal for POC applications.  
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CHAPTER 6 
PROPOSED MECHANISMS FOR CHAOTROPE-MEDIATED 
DNA-SILICA INTERACTIONS 
 
6.1 MOLECULAR INTERACTIONS 
  
 The work presented in Chapters 4 and 5 demonstrated that low pH and the 
addition of a chaotropic agent maximized DNA adsorption on the silica surface. The 
phenomenon was analyzed by Melzak et al. in 1996 through bulk depletion experiments 
by saturating a silica surface with salmon sperm DNA.11 A mechanism was proposed 
based on the following reaction: 
 
DNA (hydrated) + silica (hydrated) + counterions ⇋ neutral DNA-silica complex + water 
 
Equilibrium could be reached by three competing interactions: 1) electrostatic repulsion 
forces, 2) dehydration effects, and 3) hydrogen bonding.11 Electrostatic repulsion was 
previously discussed in Chapter 2. Due to the DNA’s pI at pH 5 and silica’s pKa at  
pH 4.5 and 8.5, the electrostatic behavior of both depended on pH, resulting in increased 
electrostatic repulsion with increasing pH. This repulsion is counteracted by dehydration 
effects induced by the presence of a chaotropic, which provides the driving force for the 
DNA to bind to the silica surface. Once on the surface, hydrogen bonding between the 
silica and DNA complete the adsorption process. This specific mechanism was proposed 
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based on globular protein adsorption on PS surfaces.61 Although this was a poor 
comparison to DNA and silica, since proteins have more complex structure than DNA 
and silica is not a purely hydrophobic surface like PS. The model, however, did fit the 
results, and previous literature has demonstrated that ions with low charge density, like 
chaotropes, preferentially adsorb onto hydrophobic surfaces.97 
 The results in Chapter 5 corroborate most of the proposed mechanism. Given the 
interplay of electrostatic repulsion, dehydration, and hydrogen bonding formation, 
adsorption occurred when dehydration effects and hydrogen bond formation were 
stronger than electrostatic repulsion. We observed increased adsorption at low pH 
controlling for chaotrope presence, when electrostatic repulsion was expected to be at a 
minimum. Additionally, more than 99.9% of the DNA adsorbed on the surface at pH 3 
buffer only solution, in the absence of a chaotrope. In fact, the buffering ion for pH 3, 
formate, is kosmotropic.12 This adsorption cannot be explained by the Melzak model, 
which requires a chaotrope to drive the dehydration effects. In the presence of chaotrope, 
the increase in adsorption can be attributed to chaotrope-induced dehydration effects.96 
Thus, the data suggests that a similar drive already exists at low pH for DNA to adsorb on 
the silica surface, likely due to the passivation of electrostatic repulsion from pH effects 
protonating the silanols and phosphate groups. This was further corroborated by the 
results in Section 5.4 where DNA-silica interactions at low pH were dominated by 
hydrophobic forces. DNA recoveries with low ionic and high ionic buffers were poor, 
while recoveries using solutions that disrupt hydrogen bonding (95 °C formamide), or 
dissolve the surface (1 M NaOH) significantly larger. Increased recovery suggested that 
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molecular interactions during adsorption were dominated by hydrophobic forces and 
secondarily by hydrogen bonding. 
 Additional experiments could be done to confirm the proposed mechanism. First 
when designing any future experiment, it’s important to keep track of the DNA amount to 
silica surface area ratio. Previous literature has produced high DNA recoveries with low 
salt, high pH buffers, such as Buffer EB, due to the overabundance of DNA on the silica 
surface.33 Further experiments can be done to understand the boundary between DNA-
limited and DNA-in-excess reactions. For DNA-limited samples, one can repeat the 
experiment in Section 5.4 to explore how well different elution buffers recover DNA 
adsorbed with different adsorption buffers. For adsorbed at higher pH we expect the 
recovery using 95 °C formamide to approach the recovery using 1 M NaOH. This would 
indicate hydrogen bonding to be more dominant that hydrophobic effects due the 
expected increase of electrostatic repulsion. In addition, this should also hold for DNA 
adsorbed in the absence of a chaotrope as this decreases the dehydration effects. It is 
important to note that results would also be influenced by the silica used to run these 
experiments. 
 
6.2 ADSORPTION MODEL 
 
 Vandeventer et al. proposed that adsorption was multi-phasic in 2012.13 They 
analyzed transient adsorption of salmon sperm DNA on silica-coated sensors using quartz 
crystal microbalance (QCM). Usually, the Sauerbrey equation: 
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Δm = 
–CΔFn
n  
where Δm is the change in mass, C is constant, n is the overtone, and ΔFn is change in 
frequency of overtone n, can be used to calculate adsorbed mass on the sensor surface by 
the change in frequency.98 However, this cannot be used for DNA adsorption since the 
equation assumes the formation of a thin, rigid monolayer. Instead, one can analyze ΔDn 
vs. ΔFn plots, where ΔDn is the change in dissipated energy for given overtone n as shown 
  
Figure 37. ΔDn vs. ΔFn plot comparing effect of pH on DNA adsorption in solutions 
containing 0.25 M glycine for n = 3. Three solutions also included 400 mM KCl at pH 5 
(open circles), 200 mM KCl at pH 5 (closed circles), and 400 mM KCl at pH 6 (open 
triangles). Data is average of triplicate runs.13 
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in Figures 37 and 38. The slope indicates the rigidity of the adsorbed film. In other 
words, smaller slopes (|ΔDn/ΔFn|) indicate increased rigidity, while larger slopes indicate 
more viscoelastic behavior.99 
Two results can be inferred from Figures 37 and 38. Figure 37 shows that at pH 5, 
DNA forms a more tightly bound layer on the silica, which behaves initially rigidly. After 
more DNA adsorbs, the layer becomes more disorganized, and behaves in a more viscous 
manner. At pH 6, only viscoelastic layers are formed, as shown in Figure 38. The 
multiphasic behavior was enhanced with the presence 6 M of chaotropic NaClO4. The 
figures also show increased adsorption at low pH and in the presence of a chaotrope, as 
demonstrated by the larger |ΔFn| reached using those conditions. This is similar to the 
results in Chapter 5 where adsorption increased with low pH, and was further enhanced 
in the presence of a chaotrope. It is worth noting that even if the Sauerbrey equation 
cannot be accurately be used to quantify the amount of adsorbed DNA, changes in |ΔFn| 
still correlate to changes in amount of adsorbed material. However, one cannot directly 
differentiate between increased DNA adsorption or increased water retention by the 
already adsorbed layer. However, since chaotropes are known to exhibit dehydration 
effects, one can assumption that increases in |ΔFn| is a result of additional DNA 
adsorption, specifically for solutions containing chaotropic agents.  
Additionally, QCM data cannot differentiate between multiple adsorbed layers. 
The data collected characterizes the adsorbed film as a whole, and cannot determine the 
existence of multilayered adsorption.100 This is especially true when analyzing the 
rigidity of an adsorbed film. Specifically, it cannot differentiate between a viscoelastic 
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monolayer and an adsorbed bilayer made of a top viscoelastic layer on top of a rigid 
layer. This can confound the interpretation of results at a given ΔFn value.  
 
Figure 38. ΔDn vs. ΔFn plot comparing solution composition at pH 5 on DNA adsorption 
for n = 3. The four solutions contained 6 M NaClO4 (closed circles), 0.25 M glycine and 
400 mM KCl (open circles), 0.25 CH3COOH and 400 mM K+ (closed triangles), and 0.2 
M NaC6H7O7 and 400 mM KCl (open triangles). Data is average of triplicate runs.13 
 
  Vandeventer et al. concluded that DNA adsorbed initially rigidly, and then 
became viscoelastic on the surface. They generated a set of equations to describe the 
mechanism based on a qualitative model displayed in Figure 39: 
A+ nS k!⇌
k!B 
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B k!⇌
k!C+ n− 1 S 
A+ S k!⇌
k!C 
where A is DNA in solution, B is DNA rigidly adsorbed on the silica surface, C is 
partially adsorbed DNA, S are free binding sites on the surface and n is the number of 
binding sites required for rigidly bound DNA.13 The reaction rates are labeled k1 to k6. 
They proposed a simple model where DNA in solution rigidly adsorbed to the silica 
surface and then became viscoelastic (A à B à C). DNA was assumed to not desorb 
from the surface (C à A or B à A) at low pH, thus k2, k4, k5, k6 = 0. In the presence of 
chaotrope, our results showed > 99% DNA adsorbed at low pH suggesting k2 = 0 is a safe 
assumption. However, k4 = 0 implies the existence of a drive for DNA to go back into 
solution. This contradicts the fundamental premise that DNA preferentially adsorbs to the 
surface rather than remaining in solution. Thus, DNA transitioning from being rigidly 
adsorbed to being viscoelastically adsorbed (B à C) is a poor assumption.	
 Based on the results in this thesis and Vandeventer et al.’s results, we speculate 
that adsorption is instead multilayered. Specifically, initial adsorbed DNA forms a rigid 
layer, and additional DNA adsorbs viscoelastically. The hypothesis that DNA can 
viscoelastically adsorb on the silica was examined by Vandeventer et al., by setting k2, k3, 
k4, k6 = 0. As a result, DNA in solution adsorbed rigidly on the surface (A à B) and 
partially on the surface (A à C) only.13 However, it was dismissed since they were 
unable to fit it to their data. We believe this model was too simplistic, and we propose a 
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different model that can explain the rigid-to-viscoelastic layer transition. This model, 
however, requires an additional interaction were DNA could adsorb onto rigidly adsorbed 
 
Figure 39. Model of DNA adsorption on silica surface. DNA in solution (A) are in 
equilibrium with DNA rigidly adsorbed on the surface (B), and partially adsorbed DNA 
(C). S denotes free binding sites on the silica surface.13 
DNA, as shown in Figure 40. We propose that during adsorption, DNA in solution 
adsorbs rigidly (A à B) on the silica, and as more surface is covered, additional DNA 
adsorbs partially (A à C) since smaller areas without DNA are left. Furthermore, DNA 
also adsorbs onto rigidly adsorbed DNA (A à D) resulting in the viscoelastic behavior 
Vandeventer et al. observed. We also hypothesize partially adsorbed DNA can become 
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rigidly adsorbed (C à B) as it will try to maximize its contact surface with the silica. We 
speculate DNA on DNA adsorption (A à D) is possible due to the dehydration effects 
induced by the chaotrope and pH. As a result, DNA will preferentially adsorb to another 
dehydrated DNA than remain in the polar aqueous solution. During elution with a low 
salt, high pH buffer, we anticipate that viscoelastically adsorbed DNA (D) will elute 
since it has not formed hydrophobic interactions with the silica surface. 
 
Figure 40. Proposed molecular DNA-silica interactions. DNA in solution (A) can adsorb 
rigidly (B) to the silica surface, partially (C), or adsorb onto rigidly adsorbed DNA (D). 
 To further complete the model, n is a function of chaotrope, pH, and of course the 
length of DNA, since it represents the number of surface sites a DNA molecule requires 
for rigid adsorption. Our data in Section 5.4 suggests that the adsorption capacity of silica 
is a function of chaotrope and pH, and was confirmed by previous studies. Melzak et al. 
demonstrated pH and NaClO4 amount affected the amount of DNA required to saturate 
the silica surface. Zheng et al. measured decreasing end-to-end distances of linearized 
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pBR322 plasmids via atomic force microscopy on mica with increasingly chaotropic ions 
further corroborating previous results.101 
 The benefit of the proposed changes can explain the elution results in this thesis, 
previously published literature, and the need for carrier NA in Qiagen columns. The 
difference between DNA-limiting and DNA-in-excess adsorption was discussed earlier in 
Section 5.5. DNA was poorly recovered in the DNA-limited case presented in this thesis, 
while recovery increases substantially for the DNA-in-excess case as in the commercial 
kits made by Qiagen. Based on our proposed mechanism, DNA forms a bilayer when 
adsorbing. The initial layer is rigid and DNA that is adsorbed directly on the silica 
surface is irreversibly bound, at least when eluting with a low salt, high pH. Meanwhile, 
the viscoelastic layer on top is a result of DNA adsorbing onto adsorbed DNA or partially 
adsorbed DNA, which is more loosely bound. We suspect a low salt, high pH elution 
buffer is able to disrupt the physical interactions formed by the viscoelastic layer during 
adsorption. Of course, the amount of DNA required to form the initial rigid layer depends 
on the composition of the adsorption buffer, and will affect the amount of lost DNA. 
 As with the model developed by Vandeventer et al., the model proposed here is 
also mainly qualitative. One can corroborate this model by adsorbing DNA in a 5 M 
GuSCN solution at pH 3 and collect serial Buffer EB elutions until no DNA is detectable 
in the elution. If the total amount recovered equals the input DNA, then all DNA is 
recoverable, including the proposed rigid layer. If the recovered amount is less than the 
input, then there exists DNA unrecoverable by a low salt, high pH elution. Other 
experiments may also be completed to corroborate either hypothesized mechanism, but it 
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is difficult to get direct evidence as few methods exists to directly probe molecular 
interactions at the pertinent high ionic solutions. 
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CHAPTER 7 
CONCLUSIONS 
 
This thesis set out to explore chaotrope-mediated DNA-silica interactions, when 
DNA is the limiting reagent, and to probe the interaction mechanism with the aim to 
engineer a better method for DNA recovery. A protocol was developed to adsorb DNA, 
until equilibrium was reached, and elute DNA via flowing buffer by the silica particles as 
in microfluidic devices. The design allowed for the direct quantification of unadsorbed 
DNA during the initial adsorption step, and for DNA recovered by an elution buffer. The 
experiments conducted remained in the DNA-limiting regime as ≤ 2.5 µg DNA was used. 
DNA adsorption was influenced by the aqueous environment as it increased with 
increasing acidy. Adsorption was further enhanced by adding 5 M GuSCN. Elutions with 
Buffer EB exceeded 29% DNA recovery only when DNA was initially adsorbed with  
5 M GuSCN (pH 5.2). Buffer EB was used since it is the golden standard for silica SPE 
protocols. Its low salt, high pH characteristics limit interference in downstream PCR 
reactions. Due to poor DNA recovery with Buffer EB for DNA adsorbed at 5 M GuSCN 
(pH 3), we attempted to disrupt DNA-silica-chaotrope complexes via different elution 
buffers targeting specific molecular interactions. Hot formamide and 1 M NaOH resulted 
the largest recoveries with 27.5% and 71.9% respectively for DNA adsorbed with 5 M 
GuSCN (pH 3), leading to the conclusion that the interaction are dominated by 
hydrophobic forces, while hydrogen bonding also plays a large role at low pH. However, 
neither of these buffers are practical for POC use. Our poor recovery with Buffer EB was 
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poor compared to recovery when DNA is in excess. We speculated that the discrepancy 
was due to a potential bi-layer formed during DNA adsorption where the initial adsorbed 
layer is rigidly and irreversibly bound on the silica surface, with a more viscoelastic layer 
on top that can be eluted with a low salt, high pH buffer. As our knowledge of these 
interactions improve, these systems will be better engineered to increase the range of 
clinical applications for this technology. 
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APPENDIX A 
qPCR OPTIMIZATION 
 
A.1 qPCR REACTION 
 
The following qPCR reaction combinations were examined to increase signal strength 
and lower LOD: 
1. water ....................................................................... 9.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
4 µM forward primer ............................................. 1.5 µl 
4 µM reverse primer ............................................... 1.5 µl 
20 mM dNTP ............................................................ 1 µl  
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
2.5 mM Taqman probe ........................................... 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
2. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
10 µM forward primer ........................................... 1.5 µl 
10 µM reverse primer ............................................. 1.5 µl 
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20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
3. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
9 µM forward primer ............................................. 1.5 µl 
9 µM reverse primer ............................................... 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
4. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
8 µM forward primer ............................................. 1.5 µl 
8 µM reverse primer ............................................... 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
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10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
5. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
7 µM forward primer ............................................. 1.5 µl 
7 µM reverse primer ............................................... 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
6. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
6 µM forward primer ............................................. 1.5 µl 
6 µM reverse primer ............................................... 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
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SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
7. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
5 µM forward primer ............................................. 1.5 µl 
5 µM reverse primer ............................................... 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
8. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
4 µM forward primer ............................................. 1.5 µl 
4 µM reverse primer ............................................... 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
	110 
9. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
3 µM forward primer ............................................. 1.5 µl 
3 µM reverse primer ............................................... 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
10. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
3 µM forward primer ............................................. 1.5 µl 
3 µM reverse primer ............................................... 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
11. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
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50 mM MgCl2 ........................................................ 1.5 µl 
2 µM forward primer ............................................. 1.5 µl 
2 µM reverse primer ............................................... 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
12. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
1 µM forward primer ............................................. 1.5 µl 
1 µM reverse primer ............................................... 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
13. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
10 µM forward primer ........................................... 1.5 µl 
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10 µM reverse primer ............................................. 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
7.5 mM Taqman probe ........................................... 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
14. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
10 µM forward primer ........................................... 1.5 µl 
10 µM reverse primer ............................................. 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
5 mM Taqman probe .............................................. 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
15. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
10 µM forward primer ........................................... 1.5 µl 
10 µM reverse primer ............................................. 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
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1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
2.5 mM Taqman probe ........................................... 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
16. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
10 µM forward primer ........................................... 1.5 µl 
10 µM reverse primer ............................................. 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
17. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
10 µM forward primer ........................................... 1.5 µl 
10 µM reverse primer ............................................. 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
DMSO ....................................................................... 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
	114 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
18. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
10 µM forward primer ........................................... 1.5 µl 
10 µM reverse primer ............................................. 1.5 µl 
20 mM dNTP ....................................................... 0.75 µl 
DMSO ....................................................................... 1 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
19. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
10 µM forward primer ........................................... 1.5 µl 
10 µM reverse primer ............................................. 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
DMSO .................................................................... 0.5 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
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10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
20. water ..................................................................... 10.5 µl 
core SureStart buffer .............................................. 2.5 µl 
50 mM MgCl2 ........................................................ 1.5 µl 
10 µM forward primer ........................................... 1.5 µl 
10 µM reverse primer ............................................. 1.5 µl 
20 mM dNTP ............................................................ 1 µl 
DMSO .................................................................. 0.25 µl 
1:999 diluted 1 mM ROX reference dye .............. 0.75 µl 
10 mM Taqman probe ............................................ 0.5 µl 
SureTaq polymerase ............................................. 0.25 µl 
sample ....................................................................... 5 µl 
 
A.2 qPCR TEMPERATURE PROFILES 
 
The following qPCR temperature profiles were examined to increase signal strength and 
lower LOD: 
1. 15 min 95 °C 
40 cycles: 1) 30 sec 95 °C, 2) 5 sec 65 °C, 3) 30 sec 72 °C 
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2. 15 min 95 °C 
40 cycles: 1) 30 sec 95 °C, 2) 30 sec 60 °C, 3) 30 sec 72 °C 
3. 15 min 95 °C 
40 cycles: 1) 30 sec 95 °C, 2) 30 sec 63 °C, 3) 30 sec 72 °C 
4. 15 min 95 °C 
40 cycles: 1) 30 sec 95 °C, 2) 30 sec 65 °C, 3) 30 sec 72 °C  
5. 15 min 95 °C  
40 cycles: 1) 30 sec 95 °C, 2) 30 sec 68 °C, 3) 30 sec 72 °C 
6. 15 min 95 °C 
40 cycles: 1) 30 sec 95 °C, 2) 5 sec 65 °C, 3) 15 sec 72 °C  
7. 15 min 95 °C 
40 cycles: 1) 30 sec 95 °C, 2) 5 sec 65 °C, 3) 5 sec 72 °C 
 
A.3 PRIMER AND PROBE CANDIDATES 
 
The following sequences were designed to quantify E. coli and λ-DNA, but produced 
weaker DNA signal and higher LOD than the final sequences in Section 3.3.1 and 3.3.2. 
 
1. E. coli 
i. forward primers 
5'–TGA CTT GAC GTG TCA TCC CCA CC–3' (Tm = 60 °C) 
5'–GAC CGC TGG CAA CAA AGG AT–3' (Tm = 60 °C) 
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ii. reverse primers 
5'–ATG GCT GTC GTC AGC TCG TG–3' (Tm = 60 °C) 
5'–GGA ACC GTG AGA CAG GTG CT–3' (Tm = 60 °C) 
2. mtDNA 
i. forward primers 
5'–GCA CGA AAC GGG ATC AAA CAA CC–3' (Tm = 60 °C) 
ii. reverse primers 
5'–CTG GGT CGC CTA GGA GGT CT–3' (Tm = 60 °C) 
3. λ-DNA 
i. probe 
5'–CGA GGC GGT GGC AAG GGT AA–3' (Tm = 63 °C) 
5'–CCG TAC CAT TCA GAA CTG GCA GGA–3' (Tm = 61 °C) 
5'–ATC CGT ACC ATT CAG AAC TGG CAG GA–3' (Tm = 61 °C) 
5'–TGC TAC GGC GGC AGA GT–3' (Tm = 60 °C) 
ii. forward primers 
5'–CGT GGA ATG AAC AAT GGA AGT CA–3' (Tm = 56 °C) 
5'–CAT TCA GAA CTG GCA GGA ACA G–3' (Tm = 56 °C) 
5'–CGT GGA ATG AAC AAT GGA AGT CAA CA–3' (Tm = 58 °C) 
iii. reverse primers 
5'–GCA TCC CTT TCG GCA TAC C–3' (Tm = 56 °C) 
5'–CTC GCA GAA CGG GCA TT–3' (Tm = 56 °C) 
5'–GCA TCC CTT TCG GCA TAC CA–3' (Tm = 58 °C) 
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APPENDIX B 
ETHANOL PRECIPITATION OPTIMIZATION 
 
Ethanol precipitation was used to precipitate DNA, which is comprised of an aqueous 
phase and an alcohol phase. Optimization consisted of optimizing the aqueous phase that 
neutralized the phosphate groups on the DNA backbone and the amount of different 
alcohols. Alcohol volumes are displayed as percent of total volume (aqueous phase and 
alcohol phase). 
 
B.1 AQUEOUS COMPOSITION 
 
The aqueous phase consisted of adding salt and glycogen. Glycogen amounts ranged 1–5 
µl of 20 mg/ml glycogen. The following salts were tested at the following final 
concentrations in the aqueous phase. 
1. NaCl 
0.20 M 
0.15 M 
0.10 M 
0.05 M 
2. Sodium acetate 
0.30 M 
0.20 M 
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0.10 M 
0.05 M 
3. Ammonium acetate 
0.5 M 
0.4 M 
0.3 M 
0.2 M 
0.1 M 
 
B.2 ALCOHOL COMPOSITION AND VOLUME 
 
The following alcohols were tested and amount added is displayed in percent of total 
volume. 
1. Isopropanol 
50% 
2. 1-butanol 
40% 
30% 
20% 
3. Ethanol 
70% 
68% 
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When aqueous phase consisted of formamide: 
1. Isopropanol 
50% 
2. Tert-butanol 
50% 
55% 
60% 
62% 
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APPENDIX C 
BOOM D OPTIMIZATION 
 
Boom D optimization involved varying the Boom D volume to sample volume prior to 
ethanol precipitation. The following ratios were tested: 1:1, 2:1, 3:1, 4:1, and 5:1. 
Different washing buffers to wash the DNA pellet during ethanol precipitation were also 
tested. In addition to the standard 70% ethanol wash, solution consisting of 70% ethanol, 
12.5% Boom D, and 12.5% water was also tested.  
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APPENDIX D 
PROTOCOLS 
 
D.1 SECTION 4.1.2 PROTOCOL 
 
Coating glass capillaries with TMSPMA 
 Glass capillaries were submerged in 1 M NaOH for 1 hr. They were then rinsed 
with water, and submerged in water for 15 min. Subsequently, the capillaries were 
submerged in methanol for 30 min, and dried by incubating at 60 °C for 30 min. The 
capillaries were allowed to cool for 10 min at ambient condition before being submerged 
in a solution consisting of 50% TMSPMA and 50% methanol. The container, which held 
the submerged capillaries, was placed in a dark environment, and the capillaries were 
incubated for at least 24 hrs before adding polymerizable solution.  
 
Before adding polymerizable solution, the capillaries were submerged in methanol for  
30 min and dried at 60 °C for 30 min. 
 
D.2 SECTION 5.2 PROTOCOLS 
DNA LOSS AND RECOVERY WITH 2.5 µg INPUT DNA  
Adsorption, recovery with Buffer EB, and formamide elution 
In 1.7 ml microcentrifuge tube, 20 mg Davisil 643 silica particles were added 
with 295 µl of adsorption buffer and 5 µl 108 E. coli genomic DNA, the equivalent of  
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2.5 µg. The adsorption buffers tested were 5 M GuSCN (pH 3 and 8), 5 M GuHCl (pH 3 
and 8), and 5 M NaSCN (pH 3 and 8). The contents of each tube were mixed by 
inversion, placed on a tube rotator, and incubated at room temperature for 1 hr. The silica 
particles were separated from the liquid phase using Millipore Ultrafree MC 0.22 µm 
centrifugal filters spun for 2 min at 12,100 x g. The aqueous filtrate was collected to 
quantify amount of DNA not adsorbed during the adsorption step: we define this as ‘Lost 
DNA’ since it was not captured by the column. The silica particles were then washed 
with 700 µl of 70% ethanol and spun twice to dry the particles. Qiagen Buffer EB was 
then used as the elution buffer for all adsorption conditions. During the elution step,  
300 µl Buffer EB was added to the silica particles, incubated for 5 min at ambient 
conditions, and then spun down. The resulting filtrate was collected to quantify the 
amount of DNA eluted from the silica particles: we define this as ‘Recovered DNA,’ 
since this protocol was used in a diagnostic device, this would be the generated purified 
sample to be used for downstream quantification methods. An addition elution was 
collected using the same method with 95 °C formamide. Since the elution volume is more 
than 70 times the CV of the silica particles, we expect the DNA elution peak to be located 
within the first eluate. As a negative control, adsorption buffer containing no DNA was 
also passed though the Millipore filters (without silica), collected, and establish the LOD. 
 
Ethanol precipitation 
The filtrates were placed in 1.7 mL microcentrifuge tubes containing 5 µl of  
20 mg/ml glycogen, 39 µl of 5 M NaCl, and 300 µl of Buffer EB. The solutions were 
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vortexed, allowed to sit for 2 min at room temperature, and then 644 µl of isopropanol 
was added, and mixed. After another 2 min of room-temperature incubation, solutions 
were spun at 17,900 x g for 15 min at 22 °C. Upon discarding the supernatant, the 
glycogen-DNA pellet was washed twice with 1 ml 70% ethanol. The supernatant was 
discarded, and the glycogen-DNA pellets were dried in ambient conditions for 15 min. 
Finally, pellets were resuspended in Buffer EB.  
 
qPCR reaction 
The DNA amount in the collected filtrates was quantified with qPCR Samples 
were amplified using SureStart Taq polymerase using an Applied Biosystems 7500 
thermocycler. The primers and Taqman probe sequences for E.coli were: 5'–ACC GCT 
GGC AAC AAA GGA TA–3' (forward primer), 5'–AGA ATG TGC CTT CGG GAC C–
3' (reverse primer) and 5'–TTG CGC TCGT TGC GGG ACT T–3' (Taqman probe) 
tagged with 6-FAM at the 5’-end and an MGBNFQ quencher at the 3’-end. Each 25 µl 
qPCR reaction consisted of 9.5 µl water, 5 µl sample, 2.5 µl Core SureStart buffer, 1.5 µl 
of 50 mM MgCl2, 1.5 µl of 4 µM forward primer, 1.5 µl of 4 µM reverse primer, 1 µl of 
20 mM dNTP, 1 µl of 100 mM DTT, 0.75 µl of 1:999 diluted 1 mM ROX reference dye, 
0.5 µl of 10 µM Taqman probe, and 0.25 µl SureStart Taq DNA polymerase and samples 
were run in duplicate on 96 well plates. The plates were initially heated at 95 °C to 
activate the polymerase and then cycled 40 times through 30 sec at 95 °C for DNA 
denaturing, 5 sec at 65 °C for primer annealing, and 30 sec at 72 °C primer extension.  
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DNA LOSS AND RECOVERY WITH 2.5 pg INPUT DNA  
Adsorption, recovery with Buffer EB, and formamide elution 
In 1.7 ml microcentrifuge tube, 20 mg Davisil 643 silica particles were added 
with 295 µl of adsorption buffer and 5 µl 105 rrsB-pGEM-T Easy vectors, the equivalent 
of 2.5 pg. The adsorption buffers tested were 5 M GuSCN (pH 3, 5.2, and 8), 5 M GuHCl 
(pH 3, 5.2, and 8), and 5 M NaSCN (pH 3, 5.2, and 8). The contents of each tube were 
mixed by inversion, placed on a tube rotator, and incubated at room temperature for 1 hr. 
The silica particles were separated from the liquid phase using Millipore Ultrafree MC 
0.22 µm centrifugal filters spun for 2 min at 12,100 x g. The aqueous filtrate was 
collected to quantify amount of DNA not adsorbed during the adsorption step: we define 
this as ‘Lost DNA’ since it would not be captured by the column. The silica particles 
were then washed with 700 µl of 70% ethanol and spun twice to dry the particles. Qiagen 
Buffer EB was then used as the elution buffer for all adsorption conditions. During the 
elution step, 300 µl Buffer EB was added to the silica particles, incubated for 5 min at 
ambient conditions, and then spun down. The resulting filtrate was collected to quantify 
the amount of DNA eluted from the silica particles: we define this as ‘Recovered DNA,’ 
since this protocol was used in a diagnostic device, this would be the generated purified 
sample to be used for downstream quantification methods. An addition elution was 
collected using the same method with 95 °C formamide. Since the elution volume is more 
than 70 times the CV of the silica particles, we expect the DNA elution peak to be located 
within the first eluate. As a negative control, adsorption buffer containing no DNA was 
also passed though the Millipore filters (without silica), collected, and establish the LOD. 
	126 
Ethanol precipitation 
The filtrates were placed in 1.7 mL microcentrifuge tubes containing 5 µl of  
20 mg/ml glycogen, 39 µl of 5 M NaCl, and 300 µl of Buffer EB. The solutions were 
vortexed, allowed to sit for 2 min at room temperature, and then 644 µl of isopropanol 
was added, and mixed. After another 2 min of room-temperature incubation, solutions 
were spun at 17,900 x g for 15 min at 22 °C. Upon discarding the supernatant, the 
glycogen-DNA pellet was washed twice with 1 ml 70% ethanol. The supernatant was 
discarded, and the glycogen-DNA pellets were dried in ambient conditions for 15 min. 
Finally, pellets were resuspended in Buffer EB.  
 
qPCR reaction 
The DNA amount in the collected filtrates was quantified with qPCR Samples 
were amplified using SureStart Taq polymerase using an Applied Biosystems 7500 
thermocycler. The primers and Taqman probe sequences for E.coli were: 5'–ACC GCT 
GGC AAC AAA GGA TA–3' (forward primer), 5'–AGA ATG TGC CTT CGG GAC C–
3' (reverse primer) and 5'–TTG CGC TCGT TGC GGG ACT T–3' (Taqman probe) 
tagged with 6-FAM at the 5’-end and an MGBNFQ quencher at the 3’-end. Each 25 µl 
qPCR reaction consisted of 9.5 µl water, 5 µl sample, 2.5 µl Core SureStart buffer, 1.5 µl 
of 50 mM MgCl2, 1.5 µl of 4 µM forward primer, 1.5 µl of 4 µM reverse primer, 1 µl of 
20 mM dNTP, 1 µl of 100 mM DTT, 0.75 µl of 1:999 diluted 1 mM ROX reference dye, 
0.5 µl of 10 µM Taqman probe, and 0.25 µl SureStart Taq DNA polymerase and samples 
were run in duplicate on 96 well plates. The plates were initially heated at 95 °C to 
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activate the polymerase and then cycled 40 times through 30 sec at 95 °C for DNA 
denaturing, 5 sec at 65 °C for primer annealing, and 30 sec at 72 °C primer extension.  
 
D.3 SECTION 5.3 PROTOCOL 
 
Adsorption and recovery 
Davisil 643 silica particles were loaded into 1.7 ml microcentrifuge tubes by 
dispensing 10 µl of a colloidal solution made from 50 mg silica particles suspended in 
220 µl ethanol. The 10 µl aliquot was then allowed to dry in an ambient environment for 
1 hr. Next, once the ethanol evaporated completely, 390 µl of the adsorption buffer and 
10 µl of λ-DNA solution were added to the silica particles. The adsorption buffers tested 
were 5 M GuSCN (pH 3, 5.2, and 8) and 0 M GuSCN (pH 3, 5.2, and 8). The net mass of 
input DNA ranged from 1 pg to 1 µg, and this corresponds to DNA concentrations 
between 2.5 pg/ml to 2.5 µg/ml. The contents of each tube were mixed by inversion, 
placed on a tube rotator, and incubated at room temperature for 1 hr. The silica particles 
were separated from the liquid phase using Millipore Ultrafree MC 0.22 µm centrifugal 
filters spun for 2 min at 12,100 x g. The aqueous filtrate was collected to quantify amount 
of DNA not adsorbed during the adsorption step: we define this as ‘Lost DNA’ since it 
was not captured by the column. The silica particles were then washed with 400 µl 70% 
ethanol and spun again to dry the particles further. Qiagen Buffer EB was used as the 
elution buffer for all adsorption conditions. For the elution step, 400 µl Buffer EB was 
added to the silica particles, incubated for 5 min at ambient conditions, and then spun 
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down. The resulting filtrate was collected to quantify the amount of DNA eluted from the 
silica particles: we define this as ‘Recovered DNA’ because if this protocol was used in a 
diagnostic device, this would be the generated purified sample to be used by downstream 
quantification methods. Since the elution volume is more than 400 times the CV of the 
silica particles, we expect the DNA elution peak to be located within the first eluate. As a 
negative control, adsorption buffer containing no λ-DNA was also passed though the 
Millipore filters (without silica), collected, and establish the LOD. 
 
Ethanol precipitation 
The filtrates were placed in 1.7 ml microcentrifuge tubes containing 5 µl of  
20 mg/ml glycogen, 30 µl of 5 M NaCl, and 65 µl of Buffer EB to a total volume of  
500 µl. The solutions were vortexed, allowed to sit for 2 min at room temperature, and 
then 1.1 ml of ethanol was added and mixed. After another 2 min of room-temperature 
incubation, solutions were spun at 17,900 x g for 15 min at 22 °C. Upon discarding the 
supernatant, the glycogen-DNA pellet was washed with twice with 1 ml of 70% ethanol. 
After discarding the supernatant, the glycogen-DNA pellets were allowed to dry in 
ambient conditions for 15 min. Finally, pellets were resuspended in Buffer EB.  
 
qPCR reaction 
The DNA amount in the collected filtrates was quantified with qPCR Samples 
were amplified using SureStart Taq polymerase using an Applied Biosystems 7500 
thermocycler. The primers and Taqman probe sequences for λ-DNA were: 5'–GTG GAA 
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TGA ACA ATG GAA GTC AAC AA–3' (forward primer), 5'–GGC AGA GTC ATA 
AAG CAC CTC ATT A–3' (reverse primer) and 5'–AGG TGC TAC GGC GGC AGA 
GT–3' (Taqman probe) tagged with 6-FAM at the 5’-end and an MGBNFQ quencher at 
the 3’-end. Each 25 µl qPCR reaction consisted of 9.5 µl water, 5 µl sample, 2.5 µl Core 
SureStart buffer, 1.5 µl of 50 mM MgCl2, 1.5 µl of 4 µM forward primer, 1.5 µl of 4 µM 
reverse primer, 1 µl of 20 mM dNTP, 1 µl of 100 mM DTT, 0.75 µl of 1:999 diluted  
1 mM ROX reference dye, 0.5 µl of 10 µM Taqman probe, and 0.25 µl SureStart Taq 
DNA polymerase and samples were run in duplicate on 96 well plates. The plates were 
initially heated at 95 °C to activate the polymerase and then cycled 40 times through  
30 sec at 95 °C for DNA denaturing, 5 sec at 65 °C for primer annealing, and 30 sec at  
72 °C primer extension.  
 
D.4 SECTION 5.4 PROTOCOL 
 
Elution curves 
Davisil 643 silica particles were loaded into 1.7 ml microcentrifuge tubes by 
dispensing 10 µl of a colloidal solution made from 50 mg silica particles suspended in 
220 µl ethanol. The 10 µl aliquot was then allowed to dry in an ambient environment for 
1 hr. Next, once the ethanol evaporated completely, 390 µl of the adsorption buffer and 
10 µl of λ-DNA solution were added to the silica particles. The adsorption buffer tested 
was 5 M GuSCN (pH 3) and the net mass of input 1 µg λ-DNA was added to 
concentrations of 2.5 µg/ml. The contents of each tube were mixed by inversion, placed 
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on a tube rotator, and incubated at room temperature for 1 hr. The silica particles were 
separated from the liquid phase using Millipore Ultrafree MC 0.22 µm centrifugal filters 
spun for 2 min at 12,100 x g. The silica particles were then washed with 400 µl 70% 
ethanol and spun again to dry the particles further. Silica samples had four 400 µl serial 
elutions collected using the following solutions: 1) 0.5 M Tris-Cl (pH 8.5), 2) 95 °C 
formamide, 3) 1 M NaOH to release DNA, 4) Buffer EB and 5) water. Elution buffers 
were incubated with the silica for 5 min at ambient conditions before being collected. 
Since the elution volume is more than 400 times the CV of the silica particles, we expect 
the DNA elution peak to be located within the first eluate. As a negative control, 
adsorption buffer containing no λ-DNA was also passed though the Millipore filters 
(without silica), collected, and establish the LOD. 
 
Ethanol precipitation 
The filtrates were placed in 1.7 mL microcentrifuge tubes containing 5 µl of  
20 mg/ml glycogen, 30 µl of 5 M NaCl, and 65 µl of Buffer EB to a total volume of  
500 µl. The solutions were vortexed, allowed to sit for 2 min at room temperature, and 
then 1.1 ml of ethanol was added and mixed. After another 2 min of room-temperature 
incubation, solutions were spun at 17,900 x g for 15 min at 22 °C. Upon discarding the 
supernatant, the glycogen-DNA pellet was washed with twice with 1 ml of 70% ethanol. 
The supernatant was removed, and the glycogen-DNA pellets were allowed to dry in 
ambient conditions for 15 min. Finally, pellets were resuspended in Buffer EB. For DNA 
filtrate samples containing formamide, the protocol was changed to account for the 
	131 
higher polarity of formamide compared to water. The 1.1 mL of ethanol during 
precipitation was replaced with 833 µl of tert-butanol.  
 
qPCR reaction 
The DNA amount in the collected filtrates was quantified with qPCR Samples 
were amplified using SureStart Taq polymerase using an Applied Biosystems 7500 
thermocycler. The primers and Taqman probe sequences for λ-DNA were: 5'–GTG GAA 
TGA ACA ATG GAA GTC AAC AA–3' (forward primer), 5'–GGC AGA GTC ATA 
AAG CAC CTC ATT A–3' (reverse primer) and 5'–AGG TGC TAC GGC GGC AGA 
GT–3' (Taqman probe) tagged with 6-FAM at the 5’-end and an MGBNFQ quencher at 
the 3’-end. Each 25 µl qPCR reaction consisted of 9.5 µl water, 5 µl sample, 2.5 µl Core 
SureStart buffer, 1.5 µl of 50 mM MgCl2, 1.5 µl of 4 µM forward primer, 1.5 µl of 4 µM 
reverse primer, 1 µl of 20 mM dNTP, 1 µl of 100 mM DTT, 0.75 µl of 1:999 diluted  
1 mM ROX reference dye, 0.5 µl of 10 µM Taqman probe, and 0.25 µl SureStart Taq 
DNA polymerase and samples were run in duplicate on 96 well plates. The plates were 
initially heated at 95 °C to activate the polymerase and then cycled 40 times through  
30 sec at 95 °C for DNA denaturing, 5 sec at 65 °C for primer annealing, and 30 sec at  
72 °C primer extension.  
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APPENDIX E 
PPM COMBINATIONS 
 
Different polymer formulas were tried before concluding on the formula used in Section 
4.1.2. They are listed below based on by polymerization method. 
 
E.1 HIPE POLYMER FORMULAS 
 
The HIPE polymer solutions were oil-in-water emulsion. The organic phase contained the 
monomer and crosslinker, while the aqueous phase contained the initiator. The surfactant 
to stabilize the final emulsion was added to the organic phase. The composition of each 
phase is described below: 
1. Organic phase:  GMA: 50 µl 
  DVB: 50 µl 
Surfactant: Span 80: 20 µl 
Aqueous phase: 5% KPS: 40 µl 
  0.1 M CaCl2: 840 µl 
2. Organic phase:  GMA: 44 µl 
  DVB: 66 µl 
Surfactant: Span 80: 20 µl 
Aqueous phase: 5% KPS: 40 µl 
  0.1 M CaCl2: 840 µl 
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3. Organic phase:  GMA: 39 µl 
  DVB: 61 µl 
Surfactant:  Span 80: 30 µl 
Aqueous phase: 5% KPS: 40 µl 
  0.1 M CaCl2: 840 µl 
4. Organic phase:  GMA: 34 µl 
  DVB: 56 µl 
Surfactant: Span 80: 40 µl 
Aqueous phase: 5% KPS: 40 µl 
  0.1 M CaCl2: 840 µl 
5. Organic phase:  GMA: 33 µl 
  DVB: 66 µl 
Surfactant: Span 80: 20 µl 
Aqueous phase: 5% KPS: 40 µl 
  0.1 M CaCl2: 840 µl 
6. Organic phase:  GMA: 66 µl 
  DVB: 33 µl 
Surfactant: Span 80: 20 µl 
Aqueous phase: 5% KPS: 40 µl 
  0.1 M CaCl2: 840 µl 
7. Organic phase:  GMA: 25 µl 
  DVB: 75 µl 
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Surfactant: Span 80: 20 µl 
Aqueous phase: 5% KPS: 40 µl 
  0.1 M CaCl2: 840 µl 
8. Organic phase:  GMA: 75 µl 
  DVB: 25 µl 
Surfactant: Span 80: 20 µl 
Aqueous phase: 5% KPS: 40 µl 
  0.1 M CaCl2: 840 µl 
 
E.2 BULK POLYMERIZATION FORMULAS 
 
Bulk polymerization solutions consisted of polymer-making components and porogen-
making components. The polymer components consisted of the monomer, cross-linker, 
and initiator and the porogen components consisted of alcohols and were not incorporated 
in the final polymer. The following compositions were tested: 
1. Polymer:  GMA: 200 µl 
  DVB: 200 µl 
Initiator: BPO: 8 mg 
Porogen: 1-dodecanol: 400 µl 
  1-butanol: 200 µl 
2. Polymer:  GMA: 250 µl 
  DVB: 250 µl 
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Initiator: BPO: 8 mg 
Porogen: 1-dodecanol: 250 µl 
  1-butanol: 250 µl 
3. Polymer:  GMA: 250 µl 
  DVB: 250 µl 
Initiator: BPO: 8 mg 
Porogen: 1-dodecanol: 167 µl 
  1-butanol: 233 µl 
4. Polymer:  GMA: 250 µl 
  DVB: 250 µl 
Initiator: BPO: 8 mg 
Porogen: 1-dodecanol: 233 µl 
  1-butanol: 167 µl 
5. Polymer:  GMA: 250 µl 
  DVB: 250 µl 
Initiator: BPO: 8 mg 
Porogen: 1-dodecanol: 250 µl 
  THF: 250 µl 
6. Polymer:  GMA: 250 µl 
  DVB: 250 µl 
Initiator: BPO: 8 mg 
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Porogen: 1-dodecanol: 250 µl 
  1-butanol: 250 µl 
7. Polymer:  GMA: 225 µl 
  DVB: 225 µl 
Initiator: BPO: 8 mg 
Porogen: 1-dodecanol: 275 µl 
  1-butanol: 275 µl 
8. Polymer:  GMA: 225 µl 
  DVB: 225 µl 
Initiator: BPO: 8 mg 
Porogen: 1-dodecanol: 233 µl 
  1-butanol: 167 µl 
9. Polymer:  GMA: 200 µl 
  DVB: 200 µl 
Initiator:  BPO: 8 mg 
Porogen: 1-decanol: 515 µl 
  THF: 85 µl 
10. Polymer:  GMA: 200 µl 
  DVB: 200 µl 
Initiator: BPO: 8 mg 
Porogen: 1-decanol: 525 µl 
  THF: 75 µl 
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11. Polymer:  GMA: 200 µl 
  DVB: 200 µl 
Initiator: BPO: 8 mg 
Porogen: 1-decanol: 535 µl 
  THF: 65 µl 
12. Polymer:  GMA: 200 µl 
  DVB: 200 µl 
Initiator: BPO: 8 mg 
Porogen: 1-decanol: 545 µl 
  THF: 55 µl 
13. Polymer:  GMA: 200 µl 
  DVB: 200 µl 
Initiator:  BPO: 8 mg 
Porogen: 1-decanol: 450 µl 
  cyclohexane: 150 µl 
14. Polymer:  GMA: 200 µl 
  DVB: 200 µl 
Initiator: BPO: 8 mg 
Porogen: 1-decanol: 400 µl 
  cyclohexane: 200 µl 
15. Polymer:  GMA: 200 µl 
  DVB: 200 µl 
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Initiator: BPO: 8 mg 
Porogen: 1-decanol: 300 µl 
  cyclohexane: 300 µl 
16. Polymer:  GMA: 200 µl 
  DVB: 200 µl 
Initiator: BPO: 8 mg 
Porogen: 1-decanol: 200 µl 
  cyclohexane: 400 µl 
17. Polymer:  GMA: 200 µl 
  DVB: 200 µl 
Initiator: BPO: 8 mg 
Porogen: 1-decanol: 400 µl 
  1-butanol: 200 µl 
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